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Abstract 
Pain Management and Comfort in Robotic Laparoscopic Prostatectomy Patients 
Kimberly A. Juhas-Davis, DrNP(c), CRNA 
Linda Wilson PhD, RN, CPAN, CAPA, BC, CNE, CHSE, CHSE-A, ANEF, FAAN 
Prostate cancer is the second most common cancer in American men with about 1 in 7 men 
being diagnosed during his lifetime.  Robotic surgery has been increasing since its inception over 
10 years ago and these procedures continue to grow and diversify. A focus on pain control, 
reducing invasiveness and promoting early discharge is a benefit and goal with use of Robotic 
Procedures.  Pain assessment and management has become a priority to many stakeholders 
including medical caregivers, patients, health care organizations and credentialing agencies. 
Although pain is reduced in minimally invasive surgery, there is a gap in the literature describing 
pain and comfort management.  A variety of pharmacologic agents have been used to treat pain 
and improve comfort in this population. Pain control modalities and treatments in this research 
focus specifically on pharmacologic modalities. Two groups were formed to differentiate use of 
opioids in Group A and opioids plus alpha 2 agonist in Group B.  After a standard of care for 
each patient, pain and comfort levels were measured and medical records were reviewed. 
Participants were placed into Group A or B depending upon their medications received.  The null 
hypothesis of this research is that there will be no difference between two standard anesthesia 
protocols with regard to pain and comfort in the perioperative setting and decreased pain will not 
be associated with increased comfort.  Data collection ceased upon completion of both groups 
and statistical analysis revealed no significant difference between Group A and Group B. 
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Chapter 1: Introduction and Overview 
Introduction 
 Pain assessment and management has become a priority to many stakeholders including 
medical caregivers, patients, health care organizations and credentialing agencies. “Pain is 
whatever the experiencing person says it is, existing whenever the experiencing person says it 
does” (McCaffery & Beebe, 1989, p. 7).  The Joint Commission (TJC) began including pain 
control as a part of the national standards and accreditation process (TJC, 2009).  California has 
passed regulations regarding pain as the 5th vial sign (State of California Department of 
Consumer Affairs, 2000) and the Veterans Administration published a 57 page toolkit 
implementing a Veteran Health Administration (VHA) National Pain Management Strategy to 
promote pain as the 5th vital sign and offer guidelines for comprehensive pain assessment 
(Department of Veteran Affairs, 2000).  Delayed hospital discharge and patient recovery from 
surgery has been associated with under treatment of postoperative pain (Pyati & Gan, 2007).  
Further, pain plays a significant role in consumer satisfaction.  Consumer satisfaction is a 
growing interest which is important to all stakeholders, including health care providers.  
Consumers satisfaction with care related to pain and comfort have been shown to be highly 
correlated to scores on the Hospital Consumer Assessment of Healthcare Providers and Systems 
(HCAHPS) survey with a Cronbach’s alpha, 0.94, and correlation coefficient 0.84 for 
communication and adequate pain control (Jha, Orav, Zheng & Epstein, 2008).   
 An early goal of nursing has been to provide comfort to patients. The General Comfort 
Questionnaire was used as part of this research and was developed by Dr. Kolcaba into a 
Comfort Theory which was first published in 1994.  Wilson and Kolcaba (2004), describe a 
comfort theory relating to nursing which depicts the importance for enhanced comfort in 
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patients.  Comfort has many meanings and connotations; it is much more than ease or relief of 
discomfort.  Holistic comfort may include physical, psychospiritual, sociocultural, and 
environmental needs (Wilson & Kolcaba, 2004).  Comfort is defined as “the immediate state of 
being strengthened through having the human needs for relief, ease, and transcendence (types of 
comfort) addressed physically, psychospiritually, socioculturally, and environmentally” (contexts 
in which comfort is experienced) (Kolcaba, 2003, p. 251).  
 Although pain is reduced in minimally invasive surgery, there is a gap in the literature 
describing pain and comfort management with therapeutic regimens.  Therapeutic regimens are 
recommended plans of care.  This may be a protocol for pain management, such as specific 
groups of medications found to be most effective for care during surgery.  A wide array of 
pharmacologic agents may be used independently or combined for pain control and comfort.  
Variation of pharmacologic selections may be practitioner dependent.  Optimizing pain control 
and comfort levels are key issues important in facilitating a rapid recovery and patient discharge.         
Overview 
 Approximately one man in seven will be diagnosed with prostate cancer during his 
lifetime (American Cancer Society, 2014).  Cancer estimates for 2015 include about 220,800 
new cases of prostate cancer diagnosed with about 27,540 deaths (American Cancer Society, 
2014).  Prostate cancer is the second most common cancer in American men only to skin cancer 
and the second leading cause of cancer death behind only lung cancer (American Cancer Society, 
2014). About one man in thirty-six will die of prostate cancer; however, this type of cancer is 
very treatable and more than 2.5 million men in the United States with prostate cancer diagnosis 
are still alive today (American Cancer Society, 2014).      
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 Seventy five million Americans suffer from serious or severe pain and 50 million of those 
people endure chronic daily pain serious enough to affect their quality of life (Yass, 2009). The 
American Pain Society has created a mission to serve people in pain through advancing research, 
education, treatment, and professional practice (American Pain Society, 2015). The under 
treatment of pain in today's society is not justified.  With a growing trend toward laparoscopic 
procedures, specifically robotic laparoscopic; it is important to determine the effectiveness of 
pain and comfort in the peri-operative period.  Pain management and comfort are important goals 
to achieve in order to facilitate and improve patient care and outcomes.  Pain control modalities 
and treatments in this research proposal focus specifically on pharmacologic modalities used in 
the Operating Room (OR) and Post Anesthesia Care Unit (PACU). 
Opioid Sparing 
 Opioid sparing is a strategy used to reduce side effects of medications (Wheeler, Oderda, 
Ashburn & Lipman, 2002).  A non-opioid medication used in combination with opioids to reduce 
opioid requirements is considered opioid-sparing and can provide up to 20-50% opioid sparing 
effects (Kehlet, 2005). Significant side effects of opioids can interfere with recovery and reduce 
a patient’s comfort level (Kehlet, 2005).  Using opioid dose sparing strategies assists in 
alleviating harsh side effects (Wheeler, Oderda, Ashburn & Lipman, 2002).  Multimodal 
balanced analgesia applies the opioid sparing technique leading to a reduction in adverse effects 
of opioids (Kehlet, 2005).  The Joint Commission has set a standard for pain management to 
reduce patients’ pain (Kehlet, 2005).  If this goal is achieved though opioids alone, there is an 
increased risk of adverse effects (Kehlet, 2005).  Although the National Institute of Health (NIH) 
practice guidelines suggest opioids be the primary mode of analgesia, concerns related to adverse 
effects are significant (Wheeler, Oderda, Ashburn & Lipman, 2002).  Many studies have shown 
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the benefits of multimodal analgesia with a variety of differing cases; however; there is limited 
information on this approach after robotic surgery.   
Multimodal Analgesia 
 Pain control modalities and treatments in this research study focus specifically on 
pharmacologic modalities. Multimodal Analgesia is one of these modalities.  Multimodal 
analgesia allows for a combination of pharmacologic agents use therefore improving 
effectiveness and reducing side effects of larger doses of any individual agent (White, 2010). 
Multimodal therapy combines analgesics with differing mechanisms of action to create a 
synergistic effect, thereby reducing total doses of each drug (Kamming, Chung, Williams, 
McGrath & Curti, 2004).  A variety of medications may provide postoperative analgesia.  
Analgesia is defined as the insensibility of pain without loss of consciousness (Merriam-Webster, 
2010).  Many different combinations of pharmacologic agents may be used to produce analgesia, 
including local anesthetics, opioids, and alpha-2 agonists.  Dexmedetomidine is an alpha-2 
adrenergic agonist which provides sedation while decreasing anesthetic use without respiratory 
depression (Davis, Waters, Vinson, Eddy & Vick, 2000).  Although opioids reduce pain, side 
effects associated with these agents may contribute to discomfort (Wu, et al., 2005). Multimodal 
analgesia or opioid sparing is a technique of pain management aimed to improve analgesia’s 
safety and efficacy through combining analgesic agents of different drug classes in order to 
reduce dosing of opioids and side effects of these individual medications (White & Kehlet, 
2010).  Multimodal balanced analgesia can help to reduce adverse outcomes generally associated 
with opioids alone (White & Kahlet, 2010).  Rationale for multimodal analgesia is to reduce the 
dose of each analgesic which improves anti-nocioception due to synergistic or additive effects; 
this may reduce the severity of side effects (Kehlet & Dahl, 1993).  Non opioid analgesics are 
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used for multimodal analgesia in order to reduce opioid requirements (White & Kahlet, 2010; 
Wheeler, Oderda, Ashburn & Lipman, 2002).  Agents such as NSAIDs, N-Methyl-D-
aspartate receptor antagonist (Ketamine), Acetaminophen, local analgesics and alpha-2 agonists 
may reduce the total dose of opioids thereby reducing potential side effects (Pyati & Gan, 2007). 
The goal of multimodal analgesia is opioid sparing which reduces postoperative morbidity and 
medication related complications (White, Kehlet & Liu, 2009; Classen, Pestotnik, Evans, Lloyd, 
& Burke 1997).  Combining analgesics from differing drug classes improves safety and efficacy 
through the variety of each drugs mechanism of action (White & Kehlet, 2010).     
Pharmacologic Agents 
 A variety of medications may provide postoperative analgesia.  Analgesia is defined as 
the insensibility of pain without loss of consciousness (Merriam-Webster, 2010).  Many different 
combinations of pharmacologic agents may be used to produce analgesia, including local 
anesthetics, opioids, and alpha-2 agonists (Wheeler, Oderda, Ashburn & Lipman, 2002).  
Opioids used in this study were fentanyl and hydromorphone.  Dexmedetomidine is an alpha-2 
adrenergic agonist which provides sedation while decreasing anesthetic use without respiratory 
depression (Davis, Waters, Vinson, Eddy & Vick, 2000).  Dexmedetomidine is the alpha-2 
agonist which was used in this study.  The medications of interest given in the OR and PACU 
will have an effect on patient pain and comfort upon awakening from anesthesia in the PACU 
which is the reason both areas are included in this study.  Anesthesia providers are the 
individuals who determine which medications are given and what dose is required.  Due to 
physiologic implications of the pharmacokinetics and pharmacodynamics of dexmedetomidine 
combined with surgical implications of positioning and insufflation, this study allowed for 
provider standard of care in their choice of medication regimen only to be reviewed after 
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completion of care.  Medications were dosed as provider standard of care and totaled in each 
area representing the cumulative effects of medications given and measuring the effects in the 
PACU and final measurement in the patient room after discharge from PACU.  Although opioids 
reduce pain, side effects associated with these agents may contribute to discomfort (Wu, et al., 
2005).  Further, use of local anesthetics at port and incision sites can improve patients’ pain and 
comfort, and further reduce opioid requirements.   
 The two standards of care anesthetic regimens for this research provide further 
information on both the multimodal balanced analgesia and opioids alone approach to pain 
management.  Further identification of single agent pain control compared to two agents will 
guide our practice to the best pain management strategy for this robotic laparoscopic procedure.  
Therefore the two protocol groups are those participants who received opioids alone and those 
who received opioids with an α 2 agonist.   
Purpose 
 The purpose of this study was to determine the best pain management strategy for this 
robotic laparoscopic procedure, both improving pain control and comfort for a facilitated 
recovery and expedited discharge from the hospital.  A procedure specific approach to peri-
operative pain management is appropriate to optimize multimodal pain management strategies 
(White & Kehlet, 2010).   
 The long-term goal of this project therefore was to develop a best practice pain 
management strategy to address the needs of Robotic Assisted Laparoscopic Prostatectomy 
(RALP) patients’ through improvement of comfort and pain control.  The objective of this study  
was to identify the relationship of pain management to comfort in this robotic surgical population 
through comparison of two standards of anesthesia care protocol in the peri-operative setting.   
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Hypotheses 
The specific aims of this project are: 
1.  Compare the effect of 2 pharmaceutical regimens on pain and comfort in the 
laparoscopic robotic prostatectomy patient.  The null hypothesis:  There will be no difference 
between two standard anesthesia protocols with regard to pain and comfort prior to surgery, 
admission to PACU after surgery, discharge from PACU, and admission to the Surgical Unit. 
2.  Explore the relationship between pain and comfort in post-operative RALP patients.  
The null hypothesis:  Decreased pain will not be associated with increased comfort. 
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Chapter 2: Background and Significance 
Cancer Prevalence  
 According to the World Health Organization (WHO), cancer was a leading cause of death 
worldwide, with an estimated 7.9 million deaths in 2007 and 8.2 million in 2012 accounting for 
13% of all deaths (ACS, 2007; WHO, 2014; ACS, 2014).  Projections of cancer death rates by 
2050 are estimated to be 17.5 million individuals (ACS, 2014).  Early detection of prostate 
cancer accounts for the increasing rates in the United States with wide use of prostate screening 
antigen (PSA) testing (ACS, 2008).  Early treatment allows for decreasing death rates in 
developed countries (ACS, 2007).  After the age of 50, prostate cancer risk increases 
exponentially (NCI, 2014). In the United States from 2002-2006, the median age at death for 
cancer of the prostate was 80 years of age (NCI, 2006). Approximately 0.0% died under age 20; 
0.0% between 20 and 34; 0.1% between 35 and 44; 1.4% between 45 and 54; 7.2% between 55 
and 64; 20.1% between 65 and 74; 40.9% between 75 and 84; and 30.3% 85+ years of age (NCI, 
2006).  The prevalence as of January 1, 2006, was approximately 2,177,975 men alive who had a 
history of cancer of the prostate in the United States (NCI, 2006).  Estimates of prostate cancer 
diagnosis increased from 185,895 men diagnosed in 2005 (CDC, 2009) to 186,320 men 
diagnosed with prostate cancer in 2008 (ACS, 2008).  Deaths from prostate cancer in 2008 were 
an estimated 28,660 in the United States alone (NCI, 2008).   
Robotic Surgery 
 the historical treatment of prostate cancer. 
 Treatment modalities range from conservative to aggressive therapy (Bickert & Frickel, 
2002).  The four main treatment modalities include, but are not limited to radical prostatectomy 
surgery, radiation therapy, androgen deprivation, or active surveillance with follow up 
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(Cooperberg, Broering & Carroll, 2009).  Standard laparoscopic approach was technically 
challenging for surgeons due to limited instrumentation, laparoscopic experience, and a 
significant learning curve (Basillote, Ahlering, Skarecky, Lee & Clayman, 2004).  The first 
robotic civilian procedure was performed in May, 2000, at Frankfurt University (Goldstraw, 
Patil, Anderson, Dasgupta & Kirby, 2007).  The advent of robotic prostate surgery has grown 
significantly in the past ten years.         
 robotic assisted laparoscopic prostatectomy:  a new surgical treatment.  
 Laparoscopic surgery alone provides a two dimensional image, non-wristed instruments, 
poor ergonomics, and counter intuitive motion while robotic surgery improves laparoscopic 
surgery through three dimensional magnified exposure and robotic instrument tip articulation 
(Thaly, Patel & Shah, 2006).  Robotics improves the ability and performance of complex open 
and laparoscopic procedures to be performed using small incisions, and reducing complication 
rates (Ficarra, Cavalleri, Novara, Aragona & Artibani, 2007; Thaly, Patel & Shah, 2006).  A high 
percentage of these complex surgical patients are discharged within 24 to 48 hours after surgery 
(Ficarra, et. al., 2007; Goldstraw, et. al., 2007; Starnes & Warren-Sims, 2006).  A prescription 
for oral narcotic pain medication is provided upon discharge which many patients only use for a 
few days (Starnes & Warren-Sims, 2010).  As of 2006, there were more than 400 robotic systems 
in the United States (Murphy, Challacombe, Khan, Dasgupta (2006).  Research areas related to 
pain management in robotic procedures is critical in order to provide the highest quality, most 
efficient and cost effective care postoperatively (Cleary & Nguyen, 2002).    
 Although open prostatectomy procedures have been performed for many years, the newer 
developed technology of robotic surgery has had a significant influence on the treatment of 
prostate cancer.  Robotic surgery allows a better view through three dimensional visualization of 
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the prostate and can reduce tremor and fatigue and enhance mobility for surgery (Murphy, 
Challacombe, Khan, Dasgupta, 2006).  While robotic outcomes can be favorable, pain control 
following surgery is an issue which needs to be addressed in this new population.  Robotic 
laparoscopic procedures are recent additions to the expanding surgical options and although the 
numbers of these procedures have been dramatically increasing, postoperative pain related 
research is still very limited in this area.  Respectively, the need to explore effective pain control 
regimens is imperative to patient care.  The postoperative period includes care during the 
immediate postoperative period in the operating room and the post anesthesia care unit (PACU), 
as well as during the days following surgery (Encyclopedia of Surgery, 2010).  Although patients 
are followed by the surgeon for up to one year after the surgery, the immediate postoperative 
period is the focus of this research (from PACU admission to transfer to medical surgical area).        
Pain and Comfort with Robotic Surgery 
 As the use of robotics continues to grow and diversify, new criteria come to light with a 
focus on pain control, reducing invasiveness and promoting early discharge.  A variety of 
pharmacologic agents have been used to treat pain and improve comfort in this population.  Each 
patient may have more than one analgesic agent which may be termed “multimodal therapy”.    
 Multimodal therapy combines analgesics with differing mechanisms of action to create a 
synergistic effect, thereby reducing total doses of each drug (Kamming, Chung, Williams, 
McGrath & Curti, 2004).  This method allows a reduction of opioid requirements and the side 
effects frequently associated with them (Kamming, et. al., 2004). Analgesia protocols may assist 
in reducing variance of practice and improve pain management (Kamming, et. al., 2004).  The 
purpose of this study was to determine the best pain management strategy for this robotic 
laparoscopic procedure, both improving pain control and comfort for a facilitated recovery and 
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expedited discharge from the hospital.  A procedure specific approach to peri-operative pain 
management is appropriate to optimize multimodal pain management strategies (White & 
Kehlet, 2010).    
 This study provides a scientific base for development of improved pharmacologic pain 
and comfort interventions for this population.  Pain and comfort in this relatively new procedure 
has not been adequately addressed.  This study provides important information about the efficacy 
of pain management in the immediate postoperative period by comparing two anesthetic 
regimens for this population.  The results could be used to guide future anesthetic practice.  
 Some research reports a reduction in postoperative pain in laparoscopic prostatectomy 
procedures, but this has not been measured in robotic surgery (Humphreys, Gettman, Chow, 
Zincke & Blute, 2004).  Further statements of proposed benefits of RALP have included reduced 
postoperative pain (Goldstraw, et. al., 2007; Starnes & Warren-Sims, 2006). However, robotic 
assisted laparoscopic prostatectomy (RALP) procedures pain and comfort reports have not been 
a primary focus of research to date.  An investigation of same day surgery reported increased 
evidence that “inadequately controlled pain after ambulatory surgery is commonplace” (p. 154) 
with 82% of patients leaving the hospital in pain, 88% having pain in the four day postoperative 
period, and 35% having moderate to severe pain at home after analgesics (Watt-Watson, Chung, 
Chan & McGillion, 2004, p. 154).  Frequently comfort is reduced after RALP due to insufflation 
gas, bladder spasm, and foley catheter discomfort (Starnes & Warren-Sims, 2006).  Insufflation 
gas is an irritant to the peritoneum and may cause localized or central hypothermia leading to 
postoperative pain (Sammour, Kahokehr & Hill, 2008). Further, patients frequently feel 
abdominal distention (Starnes & Warren-Sims, 2006).  Bladder spasms are a common complaint 
and can be treated with a suppository (Starnes & Warren-Sims, 2006).  Foley catheter discomfort 
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is a patient focus postoperatively which is caused by implantation of the catheter through the 
urethra which exits at the tip of the penis (Klein, 2008).  These uncomfortable issues usually 
resolve prior to discharge.    
 Evidence of pharmacologic relationships may improve pain and comfort in this patient 
population.  A variety of medications may provide postoperative analgesia.  This study’s aim  
was to find the best combined pharmacologic therapy regimen to improve patient comfort, 
minimize pain, and safely facilitate an expedient discharge to home.  With the significant growth 
of robotic surgery throughout the United States, it is essential to implement the best pain strategy 
available (Cleary & Nguyen, 2002).  Application of standardized pain evaluation and treatment 
modalities may lead to improvements in patient care (White & Kehlet, 2010).  Nursing plays a 
key role in delivering quality care using evidenced based practice.  Knowledge of analgesic 
pharmacology and interactions between these agents is imperative in providing excellence in 
nursing care for robotic surgery patients.   
Background Summary  
 Nursing is challenged with improving quality care and doing it with less time.  Patients 
are being discharged after RALP surgery within 24 hours.  Reducing complications while 
improving comfort and pain control are key factors for an effective strategy to improve patient 
satisfaction, and facilitate discharge to home.  The gap in the literature reviewing therapeutic 
regimens related to pain management and comfort are important to study with the growing trend 
of robotic surgery.  Reducing side effects and improving pain control and comfort in this 
population will lead to improved quality of care.    
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Chapter 3: Design and Methodology 
Overall Approach and Rationale 
 This study was an observational descriptive prospective quantitative study with a 
convenience sample.  This cross sectional study controlled for procedure type.  Groups were 
defined after treatment was complete, ensuring no manipulation of plan of care or treatment 
strategy.  A retrospective chart review was used to determine group placement of participants: 
Group A or Group B.    
 Of special note, there was a shift in the screening and treatment for prostate cancer 
guidelines (ACS, 2010) during the time of this research which dramatically reduced the number 
of robotic prostate procedures scheduled. This increased the collection time from an estimated 
one month to nearly five months.      
Site Selection 
 A convenience sample from a Philadelphia institution provided recruitment of subject 
pool.  Fox Chase Cancer Center is located in Northeast Philadelphia, PA.   
Population Sample 
 inclusion criteria. 
Adult Male subjects age 18 and older 
Those who are scheduled for RALP 
Willing to participate in study 
Anesthesia standard of care includes opioids with or without α 2 agonist 
 exclusion criteria. 
Dependent upon others to make health care decisions 
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Participant unable to complete pain and comfort information or if procedure is changed to an 
open incision. 
Applicable group at required statistical participant level 
No Opioids used 
*RALP = Robotic Assisted Laparoscopic Prostatectomy 
Methods 
 The Primary Investigator (PI) Kimberly Davis performed this research at Fox Chase 
Cancer Center after a full review and approval by Fox Chase Cancer Center IRB and in 
collaboration with Drexel University RRC & IRB.  Individuals scheduled for RALP at Fox 
Chase Cancer Center were potential participants for this study.  All adult males who met the 
inclusion criteria were offered the opportunity to participate in this research study.  These 
individuals were approached to offer participation in this study. Informed consent and HIPAA 
authorization forms were obtained.  Candidates were recruited either in the physicians’ offices or 
pre-operatively.  Upon the candidates’ interest in participation, a full explanation of the research 
was given and informed consent was obtained.  Pre-operatively, the participant was given the 
Demographic Data Sheet (DDS), The Numerical Rating Scale (NRS) and General Comfort 
Questionnaire (GCQ) to complete. Postoperatively, within ten minutes of PACU admission and 
at PACU discharge, the NRS was assessed as standard of care.  Final assessments were 
completed after participants’ arrival to medical/surgical room; the NRS and GCQ were repeated.  
Medical Record was reviewed to determine medications received intra-operatively and in PACU.  
This placed participant in Group A or B.   
 
 
PAIN AND COMFORT AFTER PROSTATE SURGERY 15 
  
 
Research Setting   
 Fox Chase Cancer Center is devoted entirely to cancer treatment, research and 
prevention. This100-bed hospital, located in Philadelphia, has been consistently ranked by U.S. 
News and World Report among the top cancer centers in the nation (Fox Chase Cancer Center, 
2014, Press Release). Fox Chase Cancer Center is an independent, nonprofit institution formed in 
1974 by the union of American Oncologic Hospital (one the nation's first cancer hospitals, 
established in 1904) and the Institute for Cancer Research (founded in 1927) (Fox Chase Cancer 
Center, 2014, Fact Sheet). The Mission of Fox Chase Cancer Center:  The mission of Fox Chase 
is to prevail over cancer, marshaling heart and mind in bold science, breakthrough medicine, and 
personal touch (Fox Chase Cancer Center, 2014, Mission).  Fox Chase Cancer Center, was the 
first acute care hospital in Pennsylvania and specialty hospital in the country to receive Magnet 
status, and has been designated for the fourth time in a row — now making it the first hospital in 
Pennsylvania to have achieved three successful Magnet renewals (Fox Chase Cancer Center 
2014, Credentials). Magnet designation is the nation's highest form of recognition for nursing 
excellence and is one of the benchmarks used to measure the quality of care patients receive (Fox 
Chase Cancer Center 2014, Credentials).  
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Figure 1 Data Collection Points & Measures 
 
Statistical Considerations 
 Specific Aim 1 was to explore the effect of 2 groups of pharmaceutical regimens on pain 
and comfort in the laparoscopic robotic prostatectomy patient.  The null hypothesis:  Pain and 
comfort will not vary among the two pharmaceutical regimens.  
Group A:  Opioids  
Group B:  Opioids + α 2 agonist 
 Data were summarized as means and standard deviation for continuous variables and 
frequencies for categorical and discrete variables.  Baseline demographics and preoperative 
variables were compared by treatment.  For the primary outcome, pain and comfort were 
measured before surgery and at 3 post surgery time points.  To test the treatment effect on pain 
scale score and comfort score, we  used a hierarchical linear modeling (HLM) where level 1 is 
the individual observation repeated over time and level 2 is the individual within which the 
observations are nested.  Compared to a more traditional repeated measure ANOVA, this 
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maximum likelihood based method will allow us to use all available data the individual provides, 
even if some of it is missing.  The researcher also adjusted for any unbalanced factors that were 
identified in the preliminary analysis by including them as covariates.  The model also included 
time of the assessment, treatment arm and the interaction between treatment and time.  Because 
this was a pilot study, adjustment for multiple comparisons was not completed. 
 Specific Aim 2:  The specific aim 2 was to explore the relationship between pain and 
comfort in the post-operative RALP patient.  The null hypothesis:  Decreased pain will not be 
associated with increased comfort. 
  A simple bivariate correlations was used.  The correlations were computed at each time 
point and tested against the correlation of zero.   
Determination of Sample Size 
 Power was first assessed for the repeated-measures ANOVAs.  Simulations have been 
shown that HLM and repeated-measures ANOVAs have similar power pattern when same data 
were used (FANG, 2006).  There will be two groups in the study:   
Group A:  Opioids 
Group B:  Opioids + α 2 agonist 
 There were two dependent variables for the ANOVAs (pain scale score, comfort score); 
each was evaluated on the interval scale of measurement.  Therefore, the study employed two, 
repeated-measures ANOVAs, one ANOVA for each of the two dependent variables.   
 A priori power was estimated for the univariate repeated-measures ANOVAs.  The 
analyses assumed that the sphericity requirement was met (Stevens, 2002; Tabachnick & Fidell, 
2007).  The analysis used a two-tailed alpha level set to .05.  Overall power was set to .80, 
meaning the study will have an 80% probability of finding a significant difference if such a 
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difference exists in the population (Field, 2009; Wickens & Keppel, 2004).  Equal sample sizes 
were assumed.  The power analysis concentrated on the multivariate group-by-time interaction 
because it usually is the least powerful element in a repeated measures ANOVA (Field, 2009; 
Wickens & Keppel, 2004).  A medium effect size was anticipated (Cohen’s {1988} f = .25).  
Results showed an overall sample size of 38 would be required (19 subjects per group), assuming 
the correlation between the observation from the same subject is at least 0.2. This sample size 
was selected as the smallest sample that would be important to detect.  Recruitment continued 
until both groups A & B of 23 per group were filled.  This assumed a 15% attrition rate.       
 The study also calculated the bivariate association between pain and comfort scores for 
robotic laparoscopic prostatectomy patients.  Therefore, a second power analysis was completed.  
Power for the bivariate analysis was set to .80. A large effect size was postulated (i.e., Cohen’s 
{1988} r = .50).  Results showed that an N of 26 would be required.  
 Given the discrepancy between the two power analyses, the more conservative sample 
size was employed.  In other words, the sample employed 46 participants.  This sample size was 
sufficient for both the repeated-measures ANOVAs and the bivariate-correlation analyses.    
Data Collection 
 demographic data sheet.   
 The demographic data sheet was formed to gather additional information which may help 
to further explain results or improve understanding for this research study.  There are many 
factors which may influence pain and comfort in the surgical patient population. These items 
were included as alternative possibilities toward impacting pain and comfort in addition to the set 
parameters of Group A and Group B.  For example, hair color may play a role in sensitivity to 
pain and local analgesics as well as general anesthesia due to mutations of melanocortin-1 
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receptor gene which governs pigment formation and leads to red hair (Liem, Joiner, Tsueda & 
Sessler, 2005).  In one study, red haired women required 19% more anesthetic than women with 
dark hair colors and redheads may be more sensitive to pain and more resistant to topical 
numbing medications than their darker hair counterparts (Liem, Joiner, Tsueda & Sessler, 2005). 
The Demographic Data Sheet (DDS) contained 14 questions.  A one-time completion of 
DDS was evaluated with an Estimated Time for DDS completion of less than five minutes.  This 
questionnaire collected data documenting age, marital status, ethnicity, education level, 
socioeconomic status, race, history of chronic pain, daily pain medication list, cigarette smoking, 
exercise, hair color & how participant deals with pain and what alternate emotional/spiritual may 
have been used in the past to improve comfort and reduce pain. Participants were instructed not 
to answer anything they were uncomfortable with.   
 numeric pain rating scale. 
 Numeric Pain Rating Scale (NRS) asked the participant to rate intensity of their pain on a 
0-10 scale.  This self-report of pain describes pain in a numeric form on a graduated scale with 0 
= No Pain and 10 = Severe pain or worst pain imaginable (NIH, 2003).  Use of the Numeric Pain 
Rating Scale has been established as reliable and valid (Williamson & Hoggart, 2005).  The NRS 
is frequently used in the postoperative period to evaluate pain.  The Numeric Pain Rating Scale 
was evaluated four times in this study (pre-op, post-op upon PACU arrival, at PACU discharge, 
and upon arrival to medical/surgical unit).  These measures were performed by registered nurses.  
Education was provided to all nurses regarding the Numeric Pain Rating Scale.  The following 
script was used to rate pain:  “On a scale of 0-10, 0 = No pain, 10 = Worst pain, please rate your 
pain.  There is no right or wrong answer”.  Estimated time to completion Numeric Pain Rating 
Scale was less than one minute.    
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 general comfort questionnaire (GCQ).   
 The General Comfort Questionnaire (GCQ) was used for this study.  The GCQ considers 
a multidimensional personal experience with varying intensity degrees (Kolcaba, 1992).  
Subscales of physical, psychospiritual, environmental and social provide the construct of comfort 
(Kolcaba, 1992).  The relationship of these subscales provides the grid for the taxonomic 
structure in a two dimensional format.  The first dimension is intensity of met/unmet comfort 
needs with the second dimension being the degree of internal and external comfort needs 
(Kolcaba, 1992).  The GCQ was generated from the taxonomic structure to measure this complex 
theory of comfort and has shown a statistically significant sensitivity in the area of comfort  
(Kolcaba, 1992).  This questionnaire was completed using a likert scale ranging from strongly 
disagree to strongly agree.  The higher the score the higher the total comfort. 
       The GCQ is a 28 item instrument using a 6 point likert scale ranging from 1 strongly 
disagree agree to 6 strongly agree (Kolcaba, 1992).  Initial results for the original form of the 
Principal Components Analysis (PCA) showed all items measuring a single construct with a 
Cronbach’s alpha = 0.88 (Kolcaba, 1992).  Thirteen factors were extracted with eigenvalue > 1 
(Kolcaba, 1992).  Revised reliabilities increased Cronbach’s alpha = 0.90 (Kolcaba, 1992).  This 
instrument showed statistically significant sensitivity in the expected directions between several 
groups (Kolcaba, 1992).  This questionnaire will be completed one time pre-op and one time 
post-operatively (medical-surgical unit).  This questionnaire takes about 10-15 minutes to 
complete.   
 chart review for grouping & data analysis. 
 Medications used in the OR and PACU were recorded as well as participant age, height, 
weight, length of PACU stay and NRS score.  
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Protection of Human Subjects 
 This study was approved by the Fox Chase Cancer Center IRB with a Full Board Review. 
Further a letter of Reliance from Drexel University IRB and Fox Chase Cancer Center IRB was 
completed. 
 Research study participants were recruited at the physicians’ offices or were recruited 
pre-operatively in the surgical department.  In a confidential setting, individuals were asked if 
interested in participating in the study, and if so, consent was obtained.  After informed consent, 
an identification number was assigned to each participant to ensure confidentiality, requesting all 
participants to place the assigned number on any paperwork that they completed.  This 
information is stored in a locked file cabinet, accessed on by the PI.  Only the PI has access to 
the research information.  Data were transcribed to a secure computer and accessed only by the 
PI.    
All data collection paperwork is kept in a locked & secure drawer in the Anesthesia 
CRNA Office with limited access only by the Primary PI.  All electronic data are stored on a 
secured username & encrypted password computer and flash (USB drive) which was locked in 
the secured information drawer when not in use by the PI.  Microsoft Office Excel & Microsoft 
Office Word documents were created for information gathering and data storage.   
This study introduced minimal risk for subjects. Vulnerable populations such as age have 
been restricted in this study setting parameters at > 18 years of age since < 18 years of age are 
considered a vulnerable population.  Informed consent clearly informed individuals of the studies 
nature provided the participants complete information about the study.  Intent to ensure 
confidentiality was clearly explained within the informed consent document.  Participants were 
given time to review the consent form as well as review written description of the purpose, 
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protocol, and risk/benefits of participating in the research study.  Participants were provided time 
for discussion, and were provided the opportunity to ask questions prior to signing the consent 
form.  The participants were asked to state the purpose and expectations of study prior to signing 
the consent form.  The Principal Investigator (PI) or Sub-Investigator obtained written informed 
consent from the candidates who met the inclusion criteria for the study.  Informed consent also 
included the discussion that research participation was voluntary and that they could withdraw 
from the study at any time.  A copy of the signed informed consent form was given to the 
participant and a copy was kept by the principal investigator.    
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Chapter 4: Data Analysis and Results 
A correlation analysis was conducted to determine the correlation between comfort and 
pain variables and repeated measures ANOVA were conducted to compare both comfort and 
pain levels according to time and group defining variables of whether the patient received opioid 
only or opioid and alpha 2 agonist pain medication post-operatively. The second repeated 
measures ANOVA (using the dependent variable of pain (NRS score) failed to demonstrate a 
normal distribution of the NRS scores by group and time, invalidating the use of the repeated 
measures ANOVA.  Therefore, between group comparisons were made in relation to average 
post-operative pain, change in post-operative pain, and individual assessments of mean pain 
scores at the different time intervals. 
Description of the Sample 
The demographic data collected included the following, the level of education, marital 
status, race, and income, frequency of exercise, frequency of chronic pain and frequency of 
taking pain medications.  The participants were divided into two groups: Group A, who received 
opioid medications, and Group B, who received a combination of opioid and alpha 2 agonist.  
Three of the Group A participants (opioids) and six of the Group B (opioids + alpha 2 agonist) 
participants did not complete all of the questions on the demographic form.  The demographic 
data from the 19 participants from Group A and 18 participants from Group B are presented in 
Table 1.  The demographic characteristics of the sample were analyzed for significant differences 
between the two groups (A and B) using a chi square analysis.  These results are also presented 
in Table 1.  None of the demographic variables demonstrate significant differences between 
groups, supporting that the groups are demographically similar. 
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Table 1  
 
Demographic Characteristics of the Sample 
  Frequency  
Variable  Group A Group B Total X2 p 
Education Level Grade School 1 1 2 
1.435 
 
.838 
 
High School 
Graduate 
4 4 8 
Some College 9 12 21 
Undergraduate 
Degree 
5 6 11 
Graduate Degree 3 1 4 
Marital Status Single 3 3 6 
1.172 
 
.760 
 
Married 16 19 35 
Widowed 1 0 1 
Divorced 2 2 4 
Income Level <$10,000 0 1 1 
3.719 
 
.715 
 
<$20,000 2 2 4 
<$25,000 1 0 1 
<$50,000 4 4 8 
<$75,000 4 2 6 
<$100,000 1 3 4 
>$100,000 7 6 13 
Race Caucasian/White  17 17 34 
.069 
 
.793 
 
Black/African 
American 
5 6 11 
Chronic Pain  No/Never 18 12 30 7.728 
 
.102 
 Rarely 2 8 10 
Occasionally 1 3 4   
Yes, Sometimes 0 1 1   
Always 1 0 1   
Pain Meds Never 9 5 14 2.394 
 
.495 
 Rarely 10 14 24 
Occasionally 2 4 6   
Weekly 0 0 0   
Daily 1 1 2   
Exercise codes Never 2 2 4 
2.293 .514 
Rarely 6 4 10 
Occasionally 10 9 19 
Regularly 4 9 13 
Hair Color Black 6 5 11 
2.394 .664 
Blonde 1 1 2 
Brunette 10 9 19 
Red/Auburn 0 2 2 
Other 5 7 12 
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Smoking History Daily 0 2 2 
2.985 .394 
Never 14 14 28 
Occasionally 1 0 1 
Quit Smoking 7 8 15 
 
In addition to the demographic data listed in Table 1, additional data were collected to 
determine the average age, height, weight, and BMI of the participants.  These data are presented 
in Table 2, with the mean (M), standard deviation (SD), and standard error (SE) given for each 
group (A and B).  The results included data from 22 participants from Group A and 24 
participants from Group B.  Table 2 also presents the results of an independent sample t-test to 
determine if these variables differ significantly according to group.  With the exception of the 
age variable, equal variances between the two groups could not be assumed and therefore, non-
pooled data were used to complete the independent samples t-test analysis.  T-test results aligned 
with those from Table 1, supporting similarity of the sample with regard to age, height, weight, 
and BMI. 
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Table 2  
Demographic Variables of Age, Height, Weight, and BMI 
Variable Group N M SD SE t p 
Age Group A  22 60.77 8.54 1.85 
1.684 .099 
Group B  24 57.08 6.23 1.27 
Height Group A  22 70.77 1.90 .405 
1.826 .075 
Group B  24 69.52 2.71 .553 
Weight Group A  22 89.89 9.60 2.05 
-.691 .494 
Group B  24 92.63 16.61 3.39 
BMI Group A  22 27.86 3.08 .657 
-1.537 .132 
Group B  24 30.50 4.74 .968 
 
Correlations  
To begin the data analysis, Pearson correlation was calculated between the comfort 
(GCQ) variable and the pain (NRS) variable at each time measure (see Table 3). The study 
incorporated two repeated measures for the GCQ data and four time measures for the NRS data. 
Correlation results failed to demonstrate any significant correlation between pain and comfort 
level in the patient sample.  
Table 3  
Correlations 
 
NRS 
time1 
NRS 
time2 
NRS 
time3 NRS time4 
GCQ 
time1 
Pearson Correlation .122 -.116 .151 -.010 
Sig. (2-tailed) .418 .442 .317 .947 
N 46 46 46 46 
      
GCQ 
time2 
Pearson Correlation -.004 -.090 -.095 .171 
Sig. (2-tailed) .979 .549 .526 .249 
N 47 47 47 47 
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General Comfort Questionnaire (GCQ)  
The second part of the data analysis was the examination of the repeated measures related 
to the comfort (GCQ) scores. Descriptive statistics of the GCQ scores over time and according to 
group are given in Table 4.  
Table 4  
Descriptive Statistics for GCQ Score by Time and Group 
 Group Mean Std. Deviation N 
GCQ time1 Group A Opioids 88.60 12.348 20 
Group B Opioids + alpha 2 agonist 81.46 11.356 24 
Total 84.70 12.218 44 
     
GCQ time2 Group A Opioids 92.90 10.427 20 
Group B Opioids + alpha 2 agonist 89.75 11.906 24 
Total 91.18 11.242 44 
 
Graphing these mean scores over time, the higher pain score trend of Group A was visualized 
(see Figure 2). 
 
 
Figure 1. Estimated Marginal Means of GCQ scores 
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 To test for significance of differences in GCQ scores by time interval and by whether or 
not the alpha 2 agonist was added to the pain medication protocol (Group A versus Group B), 
assumptions were checked for the use of the repeated measures ANOVA. Visualization of the Q-
Q plot for each group at each time interval revealed a relatively normal distribution of the data 
(Figure 3). This was checked using the Shapiro-Wilk test of normality, which supported that the 
data met the assumption of approximate normal distribution (Table 5). Because there were only 
two time intervals, Mauchly’s test was not used to check spheracity, but rather, Levene’s test was 
used to evaluate the equality of the error variances of the dependent variable, which supported 
the equal variance assumptions (p > .05) (Table 6). Therefore, the use of the repeated measures 
ANOVA was validated.  
  
  
Figure 2. Q-Q Plot distributions of GCQ scores by time and group 
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Table 5  
 
Shapiro-Wilk Tests of Normality for GCQ Data by Time and Group 
 
 
Group 
Shapiro-Wilk 
 Statistic df Sig. 
GCQ time1 Group A Opioids .963 20 .601 
Group B Opioids + alpha 2 agonist .960 24 .444 
GCQ time2 Group A Opioids .955 20 .455 
Group B Opioids + alpha 2 agonist .973 24 .753 
 
Table 6  
 
Levene’s Test of Equality of Error Variances for GCQ Data 
 
 F df1 df2 Sig. 
GCQ time1 .455 1 42 .504 
GCQ time2 .786 1 42 .380 
 
Having met the assumptions for use, the repeated measures ANOVA was conducted on 
the GCQ mean scores (comfort scores) by time (repeated measure) and group.  From Table 7, the 
F value for the “time” factor is significant (p < .001).  Thus, using the ANOVA for repeated 
measures, the mean scores for GCQ were found to be significantly different over the two time 
intervals.  However, the interaction of the time scores with group failed to demonstrate 
significance. Therefore, although over time the GCQ scores were significantly different, this 
difference was not related to group (i.e., not related to whether the patient had the addition of the 
alpha 2 agonist for pain management).  Despite the significant effect of time, no interaction with 
the experimental variable defining the two groups (opioids vs opioids + alpha 2 agonist) was 
evident.  
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Table 7  
 
Tests of Within-Subjects Contrasts 
 
Measure:    
GCQ Source time 
Type III Sum 
of Squares df 
Mean 
Square F Sig. 
Partial Eta 
Squared 
time Linear 864.819 1 864.819 17.662 .000 .296 
time * group Linear 86.909 1 86.909 1.775 .190 .041 
Error(time) Linear 2056.579 42 48.966    
 
 
Table 8  
 
Tests of Between-Subjects Effects Measuring GCQ by Time and Group 
 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Intercept 678562.737 1 678562.737 3120.690 .000 .987 
group 577.737 1 577.737 2.657 .111 .059 
Error 9132.479 42 217.440    
 
 The conclusion of the repeated measures ANOVA for the post-operative GCQ 
(comfort) scores demonstrated a significant effect related to time (time of measure), the results 
failed to demonstrate any between group differences in comfort (GCQ) over time based on 
whether or not the patient received opioid only or opioid and alpha 2 agonist post-operative pain 
medication.   
Numeric Pain Rating Scale (NRS)  
 In a similar effort to evaluate changes in reported pre and post-operative pain level 
among the patient sample, the mean NRS pain score data were evaluated using descriptive 
statistics for each of the four time interval measures (Table 9).  
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Table 9  
 
Descriptive Statistics for Pain (NRS) 
 Group Mean Std. Deviation N 
NRStime1 Group A Opioids .73 1.907 22 
Group B Opioids + alpha 2 agonist .04 .204 24 
Total .37 1.356 46 
     
NRStime2 Group A Opioids 1.50 2.596 22 
Group B Opioids + alpha 2 agonist 1.08 2.283 24 
Total 1.28 2.419 46 
     
NRStime3 Group A Opioids 2.41 2.955 22 
Group B Opioids + alpha 2 agonist .92 1.767 24 
Total 1.63 2.498 46 
     
NRStime4 Group A Opioids 2.77 2.069 22 
Group B Opioids + alpha 2 agonist 2.83 2.761 24 
Total 2.80 2.428 46 
 
Graphing these data points, the higher pain score trend of Group A was visualized, along 
with the similar fourth time measure NRS scores (see Figure 4).  
 
Figure 3. Estimated Marginal Means of NRS (pain) scores 
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         To test for significance of these differences in NRS scores by time interval and by whether 
or not the alpha 2 agonist was added to the pain medication procedures (Group A versus Group 
B), assumptions were checked for the use of the repeated measures ANOVA through generation 
of Q-Q plots, histograms, the Shapiro-Wilk test, and Mauchly’s test for spheracity, according to 
group and time interval, with repeated measures collected at four time intervals (pre-operative, 
post-operative at the PACU arrival, post-operative at PACU discharge, and post-operative at 
arrival to the medical/surgical unit).  
 Although the data upheld the assumption of spheracity with a Mauchly’s Test 
significance of p = .098, because the data failed to demonstrate a normal distribution across the 
different time measures and groups (use of Q-Q plots and Shapiro-Wilk test, p < .05 for all 
groups in the different time intervals (with the exception of time 4, in which p = .118), the results 
of the repeated measures ANOVA were not valid.  
Table 10  
 
Shapiro-Wilk Test of Normality for NRS by Time and Group (Pain) 
 
group 
Shapiro-Wilk 
 Statistic df Sig. 
NRStime1 Group A Opioids .423 22 .000 
Group B Opioids + alpha 2 agonist .209 24 .000 
     
NRStime2 Group A Opioids .643 22 .000 
Group B Opioids + alpha 2 agonist .539 24 .000 
     
NRStime3 Group A Opioids .802 22 .001 
Group B Opioids + alpha 2 agonist .589 24 .000 
     
NRStime4 Group A Opioids .929 22 .118 
Group B Opioids + alpha 2 agonist .876 24 .007 
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In an effort to understand the differences on graphic illustration between groups in terms 
of mean NRS scores at the different time measures (Figure 4), a change in pain score (NRS 
score) was calculated from the pre-operative (time 1) to the final post-operative (time 4) interval. 
The difference was then compared across the two groups.  
 Although the Shapiro-Wilk tests were significant (suggesting non-normal distribution) 
(see Table 11), given the robustness of the test and upon visualization of the Q-Q Plots and 
histograms (Figure 5), the data were deemed approximately normally distributed to allow for an 
examination using an independent sample t-test to evaluate between group differences in the 
change of NRS score from pre-operative to final post-operative data collection. In addition, the 
Levene statistic was found nonsignificant, indicating that equal variances could be assumed        
(p = .295).  
Table 11 next page 
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Table 11  
 
Shapiro-Wilk’s Test of Normality for Change in NRS Score by Group 
 
group 
Shapiro-Wilk 
 Statistic df Sig. 
Change in 
NRS score 
Group A Opioids .893 22 .022 
Group B Opioids + alpha 2 agonist .906 24 .029 
 
 
    
 
Figure 4. Q-Q Plot and Histograms for Group A and Group B for analysis of normality for the 
calculated variable of Change in NRS pain score (preoperative to postoperative). 
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         Results from the analysis suggest that although the descriptive statistics revealed a greater 
change in pain score among Group B participants compared to Group A participants (Table 12), 
this difference was not statistically significant using the independent samples t-test (p = .357) 
(Table 13).  
Table 12  
 
Group Statistics for Overall Change in NRS Mean Scores 
 
Group N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Change in 
NRS score 
Group A Opioids 22 2.0455 2.60909 .55626 
Group B Opioids + alpha 2 agonist 24 2.7917 2.81269 .57414 
 
Table 13  
 
Independent Sample t-Test for Overall Change in NRs Score (pre to post-operative) 
 
t-test for Equality of Means 
t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% CI of the 
Difference 
Lower Upper 
Change in NRS score -.930 44 .357 -.74621 .80208 -2.36270 .87028 
 
 However, because of the questionable non-normal distribution of the data, this result was 
checked against the nonparametric alternative to the independent samples t-test, the Mann-
Whitney U test.  The results of the Mann-Whitney supported the results obtained by the t-test, 
which failed to reject the null hypothesis (p =.625), indicating no significant difference across 
groups in terms of the overall change in pain level (NRS score). A similar analysis of a 
calculated variable of the average total post-operative pain (NSR) score (the sum of times 2, 3, 
and 4, divided by 3) was conducted, again using the nonparametric Mann-Whitney U test, 
supporting the conclusion that no between group differences were evident in the mean total post-
operative pain scores (p = .319)  
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 Seeking to understand the lack of significance between group differences, the researcher 
also examined the mean NRS scores at the individual time measures independently.  Descriptive 
statistics (Table 14) demonstrated higher pain scores for Group A (Opioids only) in the first three 
time measures and roughly equal mean NRS scores in the fourth time measure, aligning with the 
estimated marginal means graph presented earlier (Figure 4).  
Table 14  
 
Descriptive Statistics for NRS Variable by Time and Group 
 
group N Mean 
Std. 
Deviation 
Std. Error 
Mean 
NRStime1 Group A Opioids 22 .73 1.907 .407 
Group B Opioids + alpha 2 agonist 24 .04 .204 .042 
      
NRStime2 Group A Opioids 22 1.50 2.596 .553 
Group B Opioids + alpha 2 agonist 24 1.08 2.283 .466 
      
NRStime3 Group A Opioids 22 2.41 2.955 .630 
Group B Opioids + alpha 2 agonist 24 .92 1.767 .361 
      
NRStime4 Group A Opioids 22 2.77 2.069 .441 
Group B Opioids + alpha 2 agonist 24 2.83 2.761 .564 
 
 To examine these differences at each individual time interval separately for significance, 
the assumptions were checked to validate the use of an independent samples t-test. Q-Q plot 
visualization failed to show normal distribution of the data in any of the four time periods and 
Shapiro-Wilk tests were nearly all significant (see Table 15), indicating a violation of the 
assumption of normal distribution for the data across the sample groups.  
Table 15 next page 
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Table 15  
 
Tests of Normality 
 
group 
Shapiro-Wilk 
 Statistic df Sig. 
NRS time1 Group A Opioids .423 22 .000 
Group B Opioids + alpha 2 agonist .209 24 .000 
     
NRS time2 Group A Opioids .643 22 .000 
Group B Opioids + alpha 2 agonist .539 24 .000 
     
NRS time3 Group A Opioids .802 22 .001 
Group B Opioids + alpha 2 agonist .589 24 .000 
     
NRS time4 Group A Opioids .929 22 .118 
Group B Opioids + alpha 2 agonist .876 24 .007 
 
 Therefore, non-parametric alternative to the independent samples t-test, the Mann-
Whitney U test, was conducted to examine the data for differences in mean NRS scores across 
the two groups at each individual time measure.  Results are given in Table 16.  The only 
significant difference between groups was in the mean scores during the third time measure 
(post-operative, as PACU discharge) with the “opioids only” group (group A) demonstrating a 
significantly higher pain score compared to the group B sample of  opioids + alpha 2 agonist (p < 
.05). This result aligned with the visualized changes in the estimated marginal means graph 
presented earlier (Figure 7). The lack of significant between group differences at the other 
individual time measures (times 1, 2, and 4) likely contributed to the lack of significant between 
group differences across the repeated measure.  
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Table 16  
 
Mann-Whitney U Test Results of NRS Mean Scores at Different Times 
Distribution of NRS mean scores  Mann-Whitney U Test p-value 
Time 1 .233 
Time 2 .442 
Time 3 .050 
Time 4 .920 
 
Conclusion 
 In general, the study results failed to demonstrate any between group differences in pain 
(NRS score) or comfort (GCQ) over time based on whether or not the patient received opioid 
only or opioid and alpha 2 agonist pain medication. Time was found to have a significant effect 
on GCQ (comfort variable), but no interaction with group was noted, suggesting no group 
differences in comfort level. The only significant difference in pain level (NRS) was found at the 
time 3 measurement (post-operative at PACU discharge, at which time the Group A (Opioids 
only) demonstrated a significantly greater pain score compared to the Group B patients (Opioids 
and alpha 2 agonist). In addition, no correlation was evident between comfort (GCQ) and pain 
(NRS) variables. The study results were limited by the frequent non-normal distribution of the 
data and the relatively small group sample sizes. A larger sample size may contribute to 
enhanced results and understanding of the interactions of pain and comfort in the post-operative 
period in relation to pain management methods.  
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Chapter 5: Summary of Dissertation Research  
 
Overview 
 Patients undergoing a robotic assisted laparoscopic prostatectomy are quickly moving 
through the hospital system postoperatively toward discharge on postoperative day one through 
day four with a mean hospitalization of 1.6 days in the United States (Humphreys, Gettman, 
Chow, Zincke, Blute, 2004).  The minimally invasive robotic assisted procedure compared to 
open incision have had conflicting reports to determine if there is less pain with five small port 
incisions compared to one larger incision and if this affects the patients recovery and 
convalescence (Humphreys, Gettman, Chow, Zincke, Blute, 2004).  The effectiveness of our 
pain and comfort strategies will guide our practice toward the best pain management strategy for 
this robotic laparoscopic procedure.  
Pain management is an issue which needs to be addressed with the current advances in 
surgical technology (Carr, Reines, Schaffer, Polomano, Lande, 2005).  Laparoscopic minimally 
invasive procedures have improved patient outcomes with a decrease in blood loss, a reduction 
in overall pain and a shortened hospitalization (Humphreys, Gettman, Chow, Zincke, Blute, 
2004).     
Pain and comfort are subjective to an individual’s experience and measuring and treating 
these parameters is an important part of the surgical experience.  The importance of pain and 
comfort measurement and treatment, may help guide care in the surgical patient.  The Joint 
Commission has identified a patient right to receive effective pain and comfort management and 
institutional regulations have been designed to ensure this goal (Krenzischek & Wilson, 2003).  
To meet TJC regulations, the Agency for Healthcare, Research & Quality (AHRQ) also 
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emphasizes that safe pain management needs to be provided by institutions (Krenzischek & 
Wilson, 2003).  The American Society of Perianesthesia Nurses (ASPAN) has developed a Pain 
and Comfort Clinical Guideline to assist with the Joint Commission regulation for all individuals 
to have the right to effective pain/symptom management (ASPAN, 2015; Krenzischek & Wilson, 
2003).  This guideline begins with assessment of pain (0-10 scale) and continues with assessment 
of medical, pain and comfort history in addition to analgesic history, educational and cultural 
needs (Krenzischek & Wilson, 2003).  Interventions and post anesthesia interventions are 
presented in the guideline along with expected outcomes (Krenzischek & Wilson, 2003).   
The Institute of Medicine (IOM) has developed an initiative not only to assess and treat 
pain, but to make it a significant part of the American culture through improved awareness about 
prevention, health implications, assessment and management in healthcare and patient education 
(IOM, 2011). Further focus for the IOM’s initiative is to finance programs, address disparities, 
reduce knowledge gaps in healthcare and the general population, and improve research (IOM, 
2011).  Measurements of comfort and pain management were used for this research. The 
Numeric Pain Rating Scale were used in this research to assess pain and determine analgesia 
effectiveness.  The General Comfort Questionnaire was used to measure comfort after RALP 
procedure was performed.  Determination of the pharmacological doses required for best pain 
and comfort were determined using two groups (opioids & opioids plus alpha 2 agonist). These 
measures were important to guide effectiveness of medications used according to participant’s 
pain and comfort perception. Using a variety of analgesics may assist in minimizing unwanted 
opioid effects such as sedation, respiratory depression, nausea & vomiting along with reduced 
opioid consumption. Pain management was measured prior to surgery to document a baseline 
rating, and also measured on arrival to PACU, before discharge from PACU and upon arrival to 
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the medical/surgical room.  These time measurement intervals enabled the researcher to examine 
and re-examine the pain rating. Pain management criteria need to be developed to maintain 
control of pain and allow for expeditious discharge from the hospital after surgery 
(Michaloliakou, Chung, Sharma, 1996).  Nursing personnel need to be aware of the potential side 
effects and complications of surgical procedures and the pain management medications 
(Michaloliakou, Chung, Sharma, 1996).  Research needs to be done to determine the best 
combination of pain medication with the least possible side effects to keep the patient 
comfortable and safe (Michaloliakou, Chung, Sharma, 1996).  The nursing profession needs to 
realize their accountability for pain and comfort management and continue to improve pain and 
comfort management techniques (White, 2005). 
Authors Summary of Findings 
 The importance of pain and comfort has been described throughout this document and is 
an area of significant focus for many stakeholders including but not limited to, The Joint 
Commission, consumers and their regulating bodies, The Veterans Administration, Nursing, the 
Agency for Healthcare, Research & Quality and the Institute of Medicine (Department of 
Veteran Affairs, 2000; TJC, 2000; Jha, Orav, Zheng & Epstein, 2008).  
 There were no significant differences in group characteristics between the opioids alone 
and opioids plus alpha 2 agonist, such as age, weight, exercise, and other variables collected on 
the Demographic Data Form.  The average age of the participant was between 57-60 years old 
with some college education and married.  The mean height and weight were approximately 70 
inches and 90 kg respectively. The average participant did not experience chronic pain, took pain 
medications rarely, had brunette hair, was a non-smoker and occasionally exercised.    
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 In summary, no differences were found between groups A and B in pain (NRS score) or 
comfort (GCQ score) over time. Time was found to have a significant effect on GCQ (comfort 
variable), but no interaction with group was noted, suggesting no group differences in comfort 
level. The only significant difference in pain level (NRS) was found at the time 3 measurement 
(post-operative) at PACU discharge, at which time opioid only group demonstrated a 
significantly greater pain score compared to opioid plus alpha 2 agonist participants. 
Furthermore, there was no correlation between comfort and pain. This research was limited due 
to the relatively small group sample sizes. A larger sample size may result in different findings.  
 One significant finding in this study was an increase in NRS (pain score) during PACU 
discharge (time 3) in opioid only group with a lower pain score in the opioid plus alpha 2 agonist 
group.  This result supports the use of multi-modal analgesia.  Another difference was found in 
the GCQ (comfort) time from the first assessment to the second; however, there were no 
differences found between the specific groups’ opioid alone and opioid plus alpha 2 agonist.  
Maybe a larger study group could impact the variation in time for the comfort score (GCQ). 
This study examined a combination of modern modalities and intravenous agents 
focusing on robotic prostate surgery and the use of alpha 2 agonists with and without opioids for 
improved patient pain and comfort management.  The alpha 2 agonist (dexmedetomidine) is a 
medication which has potential to reduce total opioid requirements and reduce pain.  A recent 
study from researchers at Geneva University Hospital in Switzerland provides evidence of 
decreased opioid use in surgical patients with use of alpha 2 agonists (AANA, 2012).  
Additionally, the patients in this study had slightly less pain after their surgery (AANA, 2012). It 
is possible that no differences were noted in this study because pain was adequately controlled in 
both groups. Pain scores were noted to be higher in group A for Time 1, 2 and 3, however a 
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significance between groups was not found.  Although the results of this study did not have an 
overall significant difference between the Opioid group & Opioid and alpha 2 agonist group, 
there was some significance noted with the pain score just prior to PACU discharge between 
those participants who received the alpha 2 agonist and those who did not.  The only significant 
difference in pain level (NRS) was found at the time 3 measurement (post-operative at PACU 
discharge), at which time the opioid group demonstrated a significantly greater pain score 
compared to the opioids and alpha 2 agonist group.   
 The use of multi-modal therapy in anesthesia has been shown to reduce total dose of 
opioids; thereby reducing adverse side effects of these potent medications (Blaudszun, 
Lysakowski, Elia &Trame` r, 2012; AANA, 2012).  The Geneva University study gathered 
information from 30 different studies which included 1792 patients, 933 of them received an 
alpha 2 agonist revealing a 25-30% reduction in administered opioids and a lower postoperative 
pain score. Further, typical adverse effects of opioid medications were reduced with participants 
receiving the alpha 2 agonists (AANA, 2012; Blaudszun, Lysakowski, Elia & Trame`r, 2012). 
 Improving our understanding of the benefits of the use of alpha 2 agonists is imperative 
to continue forward movement with modern surgical interventions such as robotic surgery.  
Although there are many benefits to the use of alpha 2 agonists, precautions must be taken 
during administration.  Concerns with administration of these agents are secondary to significant 
fluctuations in hemodynamic stability with an overall reduction in blood pressure and heart rate 
(Blaudszun, Lysakowski, Elia, Trame`r, 2012).  Therefore, the use of these agents should be 
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restricted to authorized personnel and monitoring and trained personnel are required during 
administration. 
Significance to Nursing Practice 
 White & Kehlet (2010) suggest routine implementation of procedure specific evidence 
based pain management protocols to improve perioperative pain control.  This study’s aim was 
to find the best combined pharmacologic therapy to improve patient comfort, minimize pain, and 
safely facilitate an expedient discharge to home.  With the significant growth of robotic surgery 
throughout the United States, it is essential to implement the best pain strategy available (Cleary 
& Nguyen, 2002).  
 Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) data 
has shown a high correlation between patient satisfaction with hospital care, nursing 
communication, and adequate pain control (Cronbach’s alpha of 0.84) (Jha, Orav, Zheng & 
Epstein, 2008).  More recent surveys have demonstrated insufficient pain management in the 
post-operative setting (White & Kehlet, 2010).  Clinical performance data released publically has  
prompted improvements in quality of care which may lead to improvements in patient centered 
care (Jha, et al., 2008).  Further, improvements in hospital quality of clinical care have been 
prompted due to public release of HCAHPS data (Jha, et al., 2008).   
 Robotic procedures assist in expediting hospital discharge however, patient preparedness 
for home care rests in the balance. Pain and comfort are important factors to consider in our daily 
nursing practice.  Our goal to minimize pain, improve comfort and maintain safety is a continued 
balance in the times of rapid hospital discharge and minimally invasive surgery.  As our 
understanding of patients’ needs increases, and as continued research is completed we strive to 
continue improving this fine balance of pain, comfort and safety. 
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 This study did not reveal a benefit to nursing practice at this time, however; if a larger 
population were to be studied the findings might be different. 
Limitations of the Study 
 A variety of factors may have influenced the results of this research study including small 
sample size, ethnic and racial diversity, questionnaire administration (subjective), pharmaceutical 
agent selection and dosing, and lack of a control group.    Non pharmacological interventions as 
adjuvant pain and comfort control (acupuncture, relaxation, music, hypnosis, transcutaneous 
nerve stimulation) were not used in this research.  Alternative non pharmacological interventions 
could also contribute to reduction of pain.   
  The sample size was set for an 80% probability of finding a significant difference if a 
difference did exist in this population.  With the calculated medium effect size and 15% attrition 
anticipation, the estimated number of each group was 23 participants to meet the minimum 
requirement for this effect and probability.  This study had a small sample size but it was 
appropriate for a pilot study. 
 A limitation in this research design was the lack of a control group with set dosing of 
opioids and alpha 2 agonist.   Another limitation of this study was no control for dose or time of 
medication administration.  Specific doses at given times may reveal a more sensitive reflection 
of pharmacologic effect and improved comparison with the opioid alone Group A.  Further, 
comparison of larger and smaller doses could be valuable to provide information for increased or 
decreased opioid quantities required.   
 The research setting provided a limited population sample secondary to the hospital’s 
limited ethnic and racial diversity of participants.  Further analysis requirements for 
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generalization of findings are not possible with the small sample size and limitations of this 
study. 
 The General Comfort Questionnaire was completed by each participant as a self-report  
as opposed to a direct observational/questionnaire.  Personal interview for the General Comfort 
Questionnaire may possibly improve the participants’ response toward a positive or higher value. 
Although the GCQ was formulated for each participant to self-assess, an improved response in a 
positive direction may have occurred secondary to each participant receiving the questions in the 
same manner, tone, with the ability to answer questions. 
Recommendations for Future Research 
 The results of this research study demonstrated the positive finding in the NRS reduced 
pain score in Group B during time 3 which warrants further research.  Further, results may be 
improved with set dosing at a higher and lower ranges and at specific time intervals.  This 
finding provides information which further warrants future research pertaining to pain control 
and comfort with the use of alpha 2 agonists in the anesthesia and PACU settings. 
 Analgesia is an important part of pain and comfort management for all patients, but 
especially for the postoperative patient who is on the fast track for discharge.  Factors which play 
a significant role in our choices for pain and comfort management of these patients are the rapid 
discharge from the hospital, side effects of individual analgesics, specifically opioids, and the 
need for patients to continue their activities of daily living without interference from sedation. 
Taking all of this into account, our current plan can use improvement.  According to literature 
patients are still discharged to home without adequate pain control.  Healthcare providers must 
take into account and be educated in pain and comfort management of the postoperative patient 
in order to best facilitate comfort and a safe discharge from the hospital setting to home. 
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 A larger sample of participants with larger variation of diversity may improve findings.  
A recommendation for future research in a larger facility with multiple settings and a wider 
range of ethnicities and races could improve applicability to the general population.  Further 
participant assistance with questionnaire completion could improve the process of data collection 
and outcomes.  
 Patient comfort and reduced pain play a critical role in improving health care for each 
and every individual.  Continuing to search for the best pharmacologic therapeutic regimen for 
minimally invasive procedures, such as robotic assisted laparoscopic prostatectomy is an 
important research subject in order to improve pain and comfort for these patients. 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PAIN AND COMFORT AFTER PROSTATE SURGERY 48 
  
 
References 
American Association of Nurse Anesthetists AANA (2012).  Anesthesiology studies show 
promise for alpha-2 agonists to reduce opioid use. Anesthesiology Journal, May 23, 2012, 
Press Release. 
American Cancer Society (ACS) (2008). Cancer facts and figures 2008.  Retrieved December 15, 
 2009, from   
http://www.cancer.org/acs/groups/content/@nho/documents/document/2008cafffinalsecu
redpdf.pdf 
American Cancer Society (ACS) (2007).  Global cancer facts & figures 2007, American Cancer 
 Society, Atlanta, Georgia, Retrieved November 9, 2009, from   
https://www.cancer.org/acs/groups/content/@nho/documents/document/globalfactsandfig
ures2007rev2p.pdf 
American Cancer Society (ACS) (2010).  Revised prostate screening guidelines.  
What has and hasn’t changed. Retrieved April 27, 2015, from  
http://www.cancer.org/cancer/news/revised-prostate-cancer-screening-guidelines  
American Cancer Society (ACS) (2014).  What are the key statistics about Prostate Cancer? 
 Retrieved May 17, 2014, from 
  http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-statistics 
American Pain Society (APS) (2015). Mission. Southern pain society chapter. Retrieved  
March  20, 2015, from http://americanpainsociety.org/get-involved/regional-societies/sps   
American Society of Perianesthesia Nursing (2015). Pain and comfort clinical guideline. 
Retrieved April 28, 2015, from  
http://www.aspan.org/Clinical-Practice/Clinical-Guidelines/Pain-and-Comfort 
PAIN AND COMFORT AFTER PROSTATE SURGERY 49 
  
 
Basillote, J. B., Ahlering, T. E., Skarecky, D. W., Lee, D. I., & Clayman, R., 2014V. (2004).  
 Laparoscopic radical prostatectomy.  Review and assessment of an emerging technique.  
 Surgical Endoscopy, 18, 1694-1711. 
Bickert, D., & Frickel, D. (2002).  Laparoscopic radical prostatectomy.  Association of 
 Operating Room Nurses, 75(4), 762-788.  
Blaudszun, G., Lysakowski, C., Elia, N., Trame` r, M.R. (2012). Effect of perioperative systemic 
alpha 2 agonists on postoperative morphine consumption and pain intensity. Systematic 
review and meta-analysis of randomized controlled trials. Anesthesiology, 116(6), 1313-
22. 
Carr, D. B., Reines, H. D., Schaffer, J., Polomano, R. C., Lande, S. (2005).  The impact of 
technology on the analgesic gap and quality of acute pain management.  Regional 
Anesthesia and Pain Management.  30(3), 286-291. 
Centers for Disease Control and Prevention (CDC) (2009).  Prostate Cancer, Retrieved 
 November 9, 2009, from http://www.cdc.gov/cancer/prostate/index.htm   
Classen, D.C., Pestotkik, S.L., Evans, R.S., Lloyd, J.F., & Burke, J.P.  (1997) Adverse drug 
 events in hospitalized patients, excess length of stay, extra costs, and attributable 
 mortality. Journal of the American Medical Association, 277 (4), 301-306. 
Cleary, K., & Nguyen, C. (2002).  State of the art in surgical robotics:  Clinical applications and 
 technology challenges.  Computer Aided Surgery, 6(6), 312-328.  
Cooperberg, M. R., Broering, J. M., & Carroll, P. R. (2009). Risk assessment for prostate cancer 
 metastasis and mortality at the time of diagnosis.  Journal of the National Cancer 
 Institute, 101(12), 878-887.  
PAIN AND COMFORT AFTER PROSTATE SURGERY 50 
  
 
Davis, W. M., Waters, I. W., Vinson, M. C., Eddy, S., & Vick, K. (2000).  Trends in 
 pharmacology and pharmaceutical care.  New Drug approvals of 1999.  Part 2.   
Department of Veteran Affairs (2000). Pain as the 5th vital sign toolkit.  Take 5, Pain:  The 5th 
vital sign, October 2000, Retrieved November 11, 2009, from                               
 http://www1.va.gov/pain_management/docs/TOOLKIT.pdf   
Encyclopedia of Surgery (2010). Postoperative care.  Retrieved January 18, 2010 from  
 http://www.surgeryencyclopedia.com/Pa-St/Postoperative-Care.html    
Fang, H. (2006). A Monte Carlo study of power analysis of hierarchical linear model and 
 repeated measures approaches to longitudinal data analysis (Doctoral dissertation). 
 Retrieved from ProQuest Dissertations and Theses. (UMI No. 3230529) 
Ficarra, V., Cavalleri, S., Novara, G., Aragona, M., & Artibani, W. (2007).  Evidence from 
 robot-assisted laparoscopic radical prostatectomy:  A systematic review.  European 
 Urology, 51, 45-56.  
Field, A. (2009). Discovering statistics using SPSS (3rd ed.). London, EC1Y: Sage. 
Fox Chase Cancer Center (2014).  Credentials.  Fox chase awarded magnet status for  
excellence in nursing. Retrieved April 27, 2015, from 
http://www.fccc.edu/whyChoose/about/credentials/MAGNET/Magnet-Status.html  
Fox Chase Cancer Center (2014). Fact Sheet. Retrieved April 27, 2015, from,  
 http://www.fccc.edu/news/factsheet.html  
Fox Chase Cancer Center (2014). Mission Statement. Retrieved April 27, 2015, from 
 http://www.fccc.edu/information/news/publications/fighting-cancer-together.pdf  
 
 
PAIN AND COMFORT AFTER PROSTATE SURGERY 51 
  
 
Fox Chase Cancer Center (2014). Press Release. Fox chase cancer center ranked 19th among 
the nation’s top 50 hospitals for cancer care by U.S. News & World Report. Retrieved 
April 27, 2015, from  
http://www.fccc.edu/information/news/press-releases/2014/2014-07-15-USnews-Top-
Cancer-Care.html 
Goldstraw, M. A., Patil, K., Anderson, C., Dasgupta, P., & Kirby, R. S. (2007).  A selected 
 review and personal experience with robotic prostatectomy:  Implications for adoption of 
 this new technology in the United Kingdom.  Prostate Cancer and Prostatic Diseases, 
 10, 242-249. 
Humphreys, M. R., Gettment, M. T., Chow, G. K., Zincke, H., & Blute, M. L. (2004).  
 Minimally invasive radical prostatectomy.  Mayo Clinic Proceedings, 79(9), 1169-1180.  
Institute of Medicine, (2011). Relieving pain in America. A blueprint for 
 transforming prevention, care, education, and research. June 2011 Report Brief.  
Jha, A. K., Orav, E. J., Zheng, J., & Epstein, A. M. (2008).  Patients’ perception of hospital care 
 in the United States.  The New England Journal of Medicine, 359(18), 1921-1931. 
Kamming, D., Chung, F., Williams, D., McGrath, B. M., Curti, B. (2004).  Pain management in 
 ambulatory surgery.  Journal of PeriAnesthesia Nursing, 19(3), 174-182. 
Kehlet, H., & Dahl, J. B. (1993).  The value of preemptive analgesia in the treatment of 
 postoperative pain.  British Journal of Anaesthesia, 70(4).  p. 434-439.   
Kehlet, H. (2005).  Postoperative opioid sparing to hasten recovery.  Anesthesiology, 102, 1083-
 1085. 
PAIN AND COMFORT AFTER PROSTATE SURGERY 52 
  
 
Klein, A. (2008).  New catheter-less technique may ease the pain and discomfort of prostate 
 cancer recovery, New York Presbyterian Hospital.  Retrieved July 22, 2009 from  
 http://nyp.org/news/hospital/robotic-prostatectomy-technique.html   
Kolcaba, K.  (2003). Comfort theory and practice.  New York, NY:  Springer Publishers  
Kolcaba, K.  (1992). Holistic comfort:  Operationalizing the construct as a nurse-sensitive 
 outcome.  Advances in Nursing Science, 15(1), 1-10. 
Krenzischek, K. A., Wilson, L. (2003).  An introduction to the ASPAN pain and comfort clinical 
 guideline.  Journal of Perianesthesia Nursing, 18(4), 228-231. 
Liem, E. B., Joiner, T. V., Tsueda, K. , Sessler, D. I. (2005).  Increased Sensitivity to Thermal  
Pain and Reduced Subcutaneous Lidocaine Efficacy in Redheads.  Anesthesiology,   
102(3), 509–514. 
McCaffery, M., & Beebe, A. (1989).  Pain:  Clinical manual for nursing practice.  St. Louis, 
 MO:  C. V. Mosby, 1989.   
Merriam-Webster (2010). Analgesia, In Merriam-Webster Online Dictionary.   
Retrieved January   21, 2010, from  http://www.merriam-
webster.com/dictionary/analgesia    
Michaloliakou, C., Chung, F., Sharma, S., (1996).  Preoperative multimodal analgesia facilitates 
recover after ambulatory laparoscopic cholecystectomy.  Anesthesia & Analgesia.  82, 
44-51. 
Murphy, D., Challacombe, B., Khan, M. S., Dasgupta, P. (2006).  Robotic technology in urology, 
Postgraduate Medical Journal. 82(973) 743-747.   Retrieved April 27, 2015, from  
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660512/ 
PAIN AND COMFORT AFTER PROSTATE SURGERY 53 
  
 
National Cancer Institute (NCI) (2006). Surveillance epidemiology and end results (SEER) 
 statistics fact sheet, prostate.  Retrieved January 19, 2010, from 
 http://seer.cancer.gov/statfacts/html/prost.html   
National Cancer Institute (NCI) (2008).  Review of prostate cancer prevention study shows no 
 benefit for use of selenium and vitamin e supplements, Retrieved November 11, 2009, 
 from http://www.nih.gov/news/health/dec2008/nci-09.htm  
National Cancer Institute (NCI) (2014). Prostate cancer prevention. Risk Factors for prostate 
cancer development.  Retrieved April 28, 2015, from  
 http://www.cancer.gov/cancertopics/pdq/prevention/prostate/healthprofessional/page3  
National Institute of Health (NIH) (2003).  Warren Grant Magnuson clinical center.  Pain 
 intensity instruments, July 2003.  Retrieved November 25, 2009, from   
 http://www.mvltca.net/presentations/mvltca.pdf 
Pyati, S., Gan, T. J. (2007).  Perioperative pain management.  CNS Drugs, 21(3), 185-211. 
Sammour, T., Kahokehr, A., Hill, A. G. (2008). Meta-analysis of the effect of warm humidified  
 insufflation on pain after laparoscopy, British Journal of Surgery, 95(8), 950-956. 
Starnes, D. N., & Warren-Sims, T. (2006).  Care of the patient undergoing robotic-assisted 
 prostatectomy.  Urologic Nursing, 26(2), 129-137. 
State of California Department of Consumer Affairs (2000).  Pain assessment, the 5th vital sign.  
 Board of Registered Nursing, Retrieved November 11, 2009, from        
 http://www.rn.ca.gov/pdfs/regulations/npr-b-27.pdf   
Stevens, J. P. (2002). Applied multivariate statistics for the social sciences (4th ed.): Mahwah,   
 New Jersey: Lawrence Erlbaum. 
PAIN AND COMFORT AFTER PROSTATE SURGERY 54 
  
 
Tabachnick, B. G., & Fidell, L. S. (2007). Using multivariate statistics (5th. ed.). Boston, MA:    
 Pearson/Allyn & Bacon. 
Thaly, R., Patel, V. R., & Shah, K. K. (2006).  The robotic revolution.  Advancing laparoscopy 
 and urology further into the future.  Contemporary Urology, 18(10), 28, 30, 32-34, 37, 
 41, 42, 45, 46, 49.  
The Joint Commission (TJC) (2009).  Joint Commission urges patients to speak up about pain.  
 Education campaign coincides with pain awareness month, Retrieved August 10, 2009, 
 from http://www.prnewswire.com/news-releases/joint-commission-urges-patients-to-
 speak-up-about-pain-65118927.html   
Watt-Watson, J., Chung, F., Chan, V. W. S., & McGillion, M. (2004).  Pain management 
 following discharge after ambulatory same-day surgery.  Journal of Nursing 
 Management, 12, 153-161. 
Wheeler, M., Oderda, G. M., Ashburn, M.A., & Lipman, A. G. (2002).  Adverse events 
 associated with postoperative opioid analgesia: A systematic review. Clinical Journal of 
 Pain, 3, 159–180. 
White, P. F., Kehlet, H. (2010).  Improving postoperative pain management.  What are the 
 unresolved issues?  Anesthesiology, 112, 220-5.   
White, P. F., Kehlet, H., & Liu, S. (2009).  Perioperative analgesia:  What do we still know? 
 International Anesthesia Research Society, 108(5), 1364-5. 
White, P., F., (2005).  The changing role of non-opioid analgesic techniques in the management 
of postoperative pain.  Anesthesia & Analgesia.  101: S5-S22. 
Wickens, T. D. & Keppel, G. (2004).  Design and Analysis: A Researcher's Handbook.  4th 
 Edition, Englewood Cliffs, NJ: Prentice-Hall. 
PAIN AND COMFORT AFTER PROSTATE SURGERY 55 
  
 
Williamson, A., Hoggart, B. (2005).  Pain:  A review of three commonly used pain rating scales. 
 Journal of Clinical Nursing, 14, 798-804. 
Wilson, L., & Kolcaba, K. (2004).  Practical application of comfort theory in the perianesthesia 
 setting.  Journal of PeriAnesthesia Nursing, 19(3), 164-173. 
World Health Organization (WHO).  (2009). Cancer, Retrieved August 10, 2009 from       
 http://www.who.int/cancer/en/       
World Health Organization (WHO). (2014). Cancer, Key Facts, Fact Sheet N 297, February 
 2014, Retrieved May 17, 2014 from  
 http://www.who.int/mediacentre/factsheets/fs297/en/  (updated February, 2015) 
Wu, C. L., Partin, A. W., Rowlingson, A. J., Kalish, M. A., Walsh, P. C., & Fleisher, L. A.  
 (2005). Efficacy of continuous local anesthetic infusion for postoperative pain after 
 radical retropubic prostatectomy.  Adult Urology, 66, 366-370. 
Yass, M. (2009).  Chronic pain vs acute pain.  Quality health, Retrieved November 16, 2009 
 from http://www.qualityhealth.com/pain-articles/chronic-pain-vs-acute-pain    
   
 
 
 
 
 
 
 
 
 
 
 
 
PAIN AND COMFORT AFTER PROSTATE SURGERY 56 
  
 
Appendix A 
“Pain is whatever the experiencing person says it is, existing whenever the experiencing person says it does” 
McCafferty & Beebe. 
What Happens During This Study? 
The Study will be thoroughly explained to you and you will be given the opportunity to ask questions.  After 
you have an understanding of the study, you will be asked to sign a consent form.  
You may choose to withdraw from the study at any time, for any reason. This is a completely voluntary study, your care 
will not be affected whether you choose to participate in this study or not.  
You will be asked to complete a general information sheet before your surgery one time only.  This takes less than 5 
minutes to complete. 
You will be asked to rate your pain a total of four times (before surgery, immediately after surgery, before leaving the 
recovery room and upon arrival to your room. This is done routinely and takes less than 1 minute.     
You will be asked to fill out a Questionnaire about your Comfort a total of two times. Before your surgery and after you arrive 
in your room following your surgery.  This questionnaire takes about 5-10 minutes to complete. 
This study will not affect the care you receive.  After your surgery & recovery, your chart will be reviewed.  This information 
will be evaluated along with your questionnaires & pain rating information.   
What are the Risks? 
This is an Observational Study which means there is no study drug or procedure being tested.  Questionnaires will be given and 
medical records will be reviewed. 
Will my Safety Be Protected? 
Clinical Research Studies are very closely controlled and require approval by an Institutional Review Board.  This independent 
group has both medical experts and an individual from the community to safeguard individuals through assessment of risks.   
When Does the Study End? 
After the final questionnaire is complete your medical record will be reviewed to gather information concerning your pain & 
comfort surrounding your robotic surgery.  Once all groups are complete, participants’ medical information will be analyzed to 
determine whether pain & comfort were higher in one group over another. This will complete the Study.  
Fox Chase Cancer Center 
333 Cottman Avenue 
Philadelphia, PA 19111 
Call 1-888-FOX-CHASE 
 (1-888-369-2427) 
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Appendix A (continued) 
CLINICAL RESEARCH AT FOX CHASE CANCER CENTER 
__________________________________ 
IMPROVING OUR UNDERSTANTDING OF PAIN CONTROL & COMFORT AFTER A 
ROBOTIC SURGICAL PROCEDURE 
 
 
 
 
 
 
 
 
 
 
 
 
 
BROCHURE FRONT 
 
Kimberly A. Davis, DrNP(c), CRNA 
Primary Investigator 
Pager (215) 308 1262 
Kimberly.Davis@fccc.edu 
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Appendix A (continued) 
EVALUATING YOUR PAIN CONTROL & COMFORT  
Fox Chase Cancer Center Mission 
To prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention, and compassionate care.  
1.Your pain control and comfort are important factors in healthcare.   
2.By taking a few moments to complete questions about your pain and comfort during your care you will be helping to 
improve our understanding of needs for pain medicine during robotic surgery. 
3.Identifying the relationship of pain management to comfort in this robotic surgical procedure through comparison of two 
standards of anesthesia care will help to determine the best pain management strategy.  
4. Optimizing pain control and comfort levels are key issues important in promoting a rapid recovery and discharge from the 
hospital.       
5.This study will provide a scientific base for development of improved pharmacologic pain and comfort interventions.  Pain 
and comfort in this relatively new procedure has not been adequately addressed.  This study will provide important information 
about the efficacy of pain after surgery by comparing two anesthetic groups.  The results could be used to guide future anesthetic 
practice. 
What is a Clinical Research Study? 
A Clinical Research Study is an investigation which helps caregivers discover new and improved ways to treat disease and 
improve healthcare.  Research helps advance new treatment options, where smaller groups will be tested for safe and effective 
advancements in care.  
Why would you agree to take part in a Clinical Research Study? 
Choosing to take part in a Clinical research Study allows you to help others through contributing to medical research.  Although 
you may not receive any direct benefit from your participation, future advancements for treatment and care may be a result of 
your participation.  
Who can Participate? 
Screening is routine to see if you are interested and that you meet the requirements of the study.  Guidelines for each study 
describe who may be included or excluded depending on what the study needs are.  
What is a Protocol? 
A Protocol explains in detail exactly what is being studied and all of the procedures to be followed during that study. 
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Appendix A (continued) 
YOUR PAIN CONTROL & COMFORT IS IMPORTANT TO US 
__________________________________ 
Comfort is defined as… “The immediate state of being strengthened by having the human needs for relief, ease, 
and transcendence (types of comfort) addressed physically, psychospiritually, socioculturally, and 
environmentally” Wilson & Kolcaba 
By Participating in this Study, You Can Help Improve Pain Control & Comfort 
Care 
 
 
 
BROCHURE BACK 
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Appendix B 
 
 
 
INFORMED CONSENT DOCUMENT 
 
Pain Management and Comfort in Robotic Laparoscopic Prostatectomy Patients 
 
Principal Investigator:  Kimberly A. Davis, DrNP(c) CRNA 
 
This is a clinical trial, a type of research study.  Your study nurse will explain the clinical trial to 
you.  Clinical trials include only people who choose to take part.  Please take your time to make 
your decision about taking part.  You should discuss your decision with your friends and family.  
You will also discuss it with your health care team.  If you have any questions, you can ask your 
study nurse for more explanation.   
 
You are being asked to take part in this research study because you have Prostate Cancer and 
have chosen Robotic Laparoscopic Prostatectomy surgery. 
 
The sponsor of this study is Fox Chase Cancer Center. 
 
Why is this research study being done? 
 
The purpose of this study is to find out the best pain management strategy after your procedure.  
We would like to find out what combination of medications work best after your surgery.  You 
will receive the same care and medications chosen by your anesthesia provider whether or not 
you participate in this study.  These medications will be reviewed after your surgery is complete 
and compared to your pain score. We do not know if you will benefit from this research study.  
We can use what we learn from this research study to help other people with the same disease. 
 
How many people will take part in this research study? 
 
About 23 people for each group (two groups) will be needed for this research.  A total of 46 
people will take part in this research study if able to fill groups evenly.   
 
What will happen if you take part in this research study? 
 
Before you begin the research study... You will be given a Demographic Data Sheet to complete.  
Prior to surgery, The Numerical Rating Scale (NRS) and Comfort  
Questionnaire will be completed.  Postoperatively, upon arrival to the Recovery Room (Post 
Anesthesia Care Unit PACU) and at PACU discharge, the NRS will be administered.  The 
Numerical Rating Scale will be completed in the recovery area by the PACU RN.  Upon PACU 
discharge to medical/surgical room, the Numerical Rating Scale and Comfort Questionnaire will 
be completed.  Evaluation of medical record will provide medications received intraoperatively.   
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Appendix B (continued) 
 
This will place participant in Group A or B.  Further medications will be recorded from PACU 
setting.       
 
No tests or procedures will be required to participate in this study.  
 
During the research study... 
 
If you choose to take part in this research study, then you will be asked to participate in 
answering the Comfort Questionnaire information.   The Numerical Rating Scale and 
medications provided during your care are part of regular cancer treatment.  
 
• Comfort Questionnaire 
 
You will receive the Numerical Rating Scale as a part of regular cancer care.  This is being done 
no different because you are in this research study.  
 
• Numerical Rating Scale  
 
You will need no tests or procedures for this research study.  Your chart will be reviewed after 
your surgery to determine what medications you received and review your Numerical Rating 
Scale Scores.   
 
• Medication Review for group placement  
 
Questionnaires 
 
We are asking you to fill out a Demographic Data Form which is a Questionnaire that will be 
filled out one time only and takes < 5 minutes for completion.   
 
We are asking you to fill out questionnaires about comfort for this research study.  This 
questionnaire will tell us about your pain and your comfort.  You will spend 10-15 minutes to fill 
out the comfort questionnaire.  We will ask you to fill this out before your surgery one time and 
one time after your surgery to total two times during this research study. 
 
You do not have to answer any questions that make you uneasy.  Whether or not you answer any 
question will not affect your medical care.  We will keep the paper copies of the questionnaires 
in a locked file to protect your privacy.   
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Appendix B (continued) 
 
 
Study Chart  
 
 
You will receive a questionnaire one time before your surgery and one time after your surgery 
describing your comfort for this research study. This [two questionnaires from before your 
surgery until you return to your room] is called a cycle in the research time frame.  The cycle 
will be not be repeated.  The chart below shows what will happen to you during your 
participation in this research.  The left-hand column shows the day in the cycle and the right-
hand column tells you what to do on that day. 
 
 
Cycle 1 
Day  What you do 
Prior to Surgery 
Admission 
• Fill out Demographic Data Sheet, Numeric Rating Scale for pain 
& General Comfort Questionnaire (16-21 minutes total time). 
Day of Surgery  
• Report for Surgery, Fill out Numeric Rating Scale (1 minute total 
time).   
Recovery Room • Numeric Rating Scale (1 minute total time) completed in PACU. 
Admission to 
Room 
• Numeric Rating Scale & General Comfort Questionnaire (11-16 
minutes total time). 
Research after  
Admission to 
Room  
• Researcher will Review Data for Medications Received & gather 
information Numeric Rating Scale from medical record. 
Conclusion • No further information or Questionnaires Required. 
 
Future cycles 
Day What you do 
Days 1-28 
• No further information required.  Continue with surgical treatment 
plan as indicated by your surgeon. 
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Appendix B (continued) 
Study Plan  
 
Another way to find out what will happen to you during the research study is to read the chart 
below. Start reading at the top and read down the list, following the lines and arrows.  
Before your Surgery (16-21  minutes) 
Fill out Questionnaires 
 
Day of Surgery (13-18 minutes) 
Fill out Questionnaires 
 
 
Medicines used in this study 
This study will not change your medications received.  You will receive standard of 
care throughout your hospitalization.   
 
Review Medical Record After 
Information Collected to place into 
one of 2 groups (A & B) depending 
on medications received.* 
(You will be in one of two Groups)  
 
Group A:  
 
Opioids  
 
 
      
Group B:  
 
Opioids + α 2 
agonist                         
 
 
  
 
 
 
 
PAIN AND COMFORT AFTER PROSTATE SURGERY 64 
  
 
Appendix B (continued) 
 
How long will you be in the research study? 
 
The research study will be complete after you have been admitted to your Room and have 
completed the final Numeric Rating Scale & General Comfort Questionnaire.  Since there is no 
change in your care during this research, no follow up will be required.  You will continue 
follow up with your surgeon as directed.   
 
Can you stop being in the research study? 
 
Yes.  You can decide to stop at any time.  Tell the study coordinator if you are thinking about 
stopping or decide to stop.  He or she will tell you how to stop safely.  
 
It is important to tell the study coordinator if you are thinking about stopping so any risks can be 
evaluated as needed.  Another reason to tell your research coordinator that you are thinking about 
stopping is to discuss what followup care could be most helpful for you. 
 
Can you be removed from this research study? 
 
The study nurse may stop you from taking part in this research study at any time if he/she 
believes it is in your best interest; if you do not follow the research study rules; or if the research 
study is stopped. 
 
What side effects or risks can you expect from being in the research study? 
 
The study introduces little risk for subjects.  Your medical record review will reveal which group 
you will be placed into only after your care is complete.  You will not receive any specific 
medications while taking part in this research.  You will not require any blood work or testing as 
a result of participation in this research.  You should talk to your study nurse about any issues 
that you may have while taking part in the research study.  
 
Are there benefits to taking part in the study? 
 
Taking part in this study may or may not make your health better.  While your healthcare 
providers administer high quality care with monitored comfort and pain control, it would be 
more useful to compare the variety of treatment modalities.  This study may provide information 
determining a best pain management strategy for this robotic laparoscopic procedure, both 
improving pain control and comfort for a quick recovery and expedited discharge from the 
hospital.  Although there is no proof of this yet, we do know that the information from this study 
will help your healthcare team learn more about improving pain control and comfort for this 
specific type of surgery.  This information could help future cancer patients. 
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What other choices do you have if you do not take part in this research study? 
Your other choices may include: 
• Getting treatment or care for your cancer without being in a study  
• Taking part in another study  
• Getting no treatment  
 
Talk to your doctor about your choices before you decide if you will take part in this study. 
 
Will your medical information be kept private?  
We will do our best to make sure that the personal information in your medical record will be 
kept private.  However, we cannot guarantee total privacy.  Your personal information may be 
given out if required by law.  If information from this study is published or presented at scientific 
meetings, your name and other personal information will not be used.  
 
Organizations that may look at and/or copy your medical records for research, quality assurance, 
and data analysis include: 
 Fox Chase Cancer Center, Institutional Review Board 
 The National Cancer Institute (NCI) and other government agencies, like the Food and 
 Drug Administration (FDA), involved in keeping research safe for  people  
 
You will be given a separate form to review regarding the steps we will take to guard your 
privacy as part of your participation in the research study.  By signing that additional 
authorization, you will be providing your consent to use and disclose information described in 
that form connected with your participation in this research study. 
 
What are the costs? 
Taking part in this study may or may not cost your insurance company more than the cost of 
getting regular cancer treatment. 
 
Will you be compensated? 
You will not get paid for taking part in this research study.  If you are harmed because of the 
research study, we will provide the medical care to treat that harm.  However, you may have to 
pay for this treatment.  Fox Chase Cancer Center has not set aside funds to pay your salary if you 
cannot work or for any other damages if you are harmed because of the research study.   
 
What are your rights if you take part in this research study? 
Taking part in this research study is your choice.  You may choose either to take part or not to 
take part in the research study.  If you decide to take part in this study, you may leave the study 
at any time.  No matter what decision you make, there will be no penalty to you and you will not 
lose any of your regular benefits.  Leaving the study will not affect your medical care.  You can 
still get your medical care from our institution.  
 
In the case of injury resulting from this study, you do not lose any of your legal rights to seek 
payment by signing this form.  
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New findings 
We will tell you about new information or changes in the study that may affect your health or 
your willingness to continue in the study. 
 
Who can answer your questions about the research study? 
If you have questions about: Please Page: 
This study Kimberly A. Davis, DrNP(c), CRNA  
215-308-1262 
If you get sick or hurt in this study Kimberly A. Davis, DrNP(c), CRNA  
215-308-1262 
If you have a concern or complaint Director, Risk Management 
215-728-2591 
Your rights as a research participant while 
you are on this study or after the study ends 
Institutional Review Board 
215-214-3754 
Your bills or health insurance coverage Clinical Trial Financial Counselor 
215-214-1727 
 
Where can you get more information? 
You may call the National Cancer Institute's Cancer Information Service at:  
 
1-800-4-CANCER (1-800-422-6237) or TTY: 1-800-332-8615 
 
• You may also visit the NCI website at http://cancer.gov 
• For NCI's clinical trials information, go to: http://cancer.govclinicaltrials/  
• For NCI's general information about cancer, go to: http://cancer.gov/cancerinfo/  
 
 
By signing below, you tell us that you have received all of the information you need; that you 
have clear answers to your questions, and that you agree to take part in the research study.  You 
will receive a copy of this form.  You may also request a copy of the research plan.  
 
_____________________________________ ________________________ 
Signature of Participant    Date 
 
 
_________________________________________ _________________________ 
Signature of Person Obtaining Consent,   Date 
Degree  
 
By signing this form the Private Investigator obtaining consent indicates that the research 
participant has been fully informed of all aspects of the research study. 
 
Informed Consent Document Template for Clinical Trials 10/2009 
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               Appendix C 
 
 
Authorization (Permission) to Use or Disclose 
(Release) Protected Health Information (PHI) for 
Research 
IRB# and Protocol ID: IRB #11-883  
Study Title:  Pain Management and Comfort in Robotic Laparoscopic 
Prostatectomy Patients 
Principal Investigator: Kimberly A. Davis, DrNP(c), CRNA 
Coordinating Group 
(or Center): 
Fox Chase Cancer Center 
Other Sponsor(s): Drexel University 
1. What is the purpose of this form? 
This form is required by the Health Insurance Portability and Accountability Act of 1996.  
Specifically the privacy regulation (HIPAA) permits the research investigators listed above to 
use and disclose health information about you for the research study identified above which has 
been approved by the Fox Chase Cancer Center Institutional Review Board. 
The Fox Chase Cancer Center is an organization that does research to learn about the causes of 
cancer, and how to prevent and treat cancer. Researchers would like to use your protected health 
information for research. The elements of protected health information as defined by HIPAA are: 
Data Elements for Protected Health Information (PHI) 
• Names 
• All geographic subdivisions smaller than a state (except for the first 3 digits of the zip 
code in some cases) 
• All elements of dates (except year) for dates directly related to an individual (e.g., birth 
date, admission date, discharge date, date of death) and all ages over age 89 and dates 
indicative of that age 
• Telephone numbers 
• Fax numbers 
• E-mail addresses 
• Social security numbers 
• Medical record numbers 
• Health plan beneficiary numbers 
• Account numbers 
• Certificate/license numbers 
• Vehicle identifiers and serial numbers, including license plate numbers 
• Device identifiers and serial numbers 
• Web Universal Resource Locators (URL) 
• Internet Protocol (IP) addresses 
PAIN AND COMFORT AFTER PROSTATE SURGERY 68 
  
 
Appendix C (continued) 
 
• Biometric identifiers, including finger and voice prints 
• Full face photos and any comparable images 
• Any other unique identifying number, characteristic, or code 
 
2. What protected health information do the researchers want to use? 
The researchers may want to copy and use the portions of your health information that they will 
need for their research. If you enter a research study, health information that maybe used and/or 
released include the following: 
• Personal medical history; 
• Family medical history; 
• Tissue/blood/cells/DNA; 
• Content of audio/video recording of sessions; 
• Current and past cancer screening and lifestyle practices, medications, therapies, 
diagnostic tests, surgeries, and/or biopsies; 
• Information from a genetic test you may have had in the past (for example, 
BRCA1 and/or BRCA2 testing) 
• Any information collected in the Health History Questionnaire and/or other 
survey instruments completed during the course of the study. 
You may request a blank copy of the data forms from the study doctor or his/her research staff to 
learn what information will be shared. 
 
3. Why do the researchers want my protected health information? 
Fox Chase Cancer Center will collect your protected health information and share it with the Fox 
Chase Cancer Center Biostatistical Center if you enter a research study. The center will use your 
information in their cancer research study. 
 
4. Who will be able to use my protected health information? 
Fox Chase Cancer Center will use your health information for research. As part of this research, 
it may give your information to the following groups taking part in the research. Fox Chase 
Cancer Center may also permit these groups to come in to review your original records that are 
kept by Fox Chase Cancer Center so that they can monitor the research study. 
• The Fox Chase Cancer Center Biostatistical Center 
• Public health agencies and other government agencies (including non-U.S.) as authorized 
or required by law; 
• Other people or organizations assisting with research efforts of the Fox Chase Cancer 
Center 
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5. How will information about me be kept private? 
Fox Chase Cancer Center will keep all health information private to the extent possible. Only 
researchers working with Fox Chase Cancer Center or the sponsor will have access to your 
information. Fox Chase Cancer Center or the sponsor will not release personal health 
information about you to others except as authorized or required by law. However, once your 
information is given to other organizations that are not required to follow federal privacy laws, 
we cannot assure that the information will remain protected. 
 
6. What happens if I do not sign this permission form? 
If you do not sign this permission form, you will not be able to take part in the research study for 
which you are being considered. 
 
7. If I sign this form, will I automatically be entered into the research study? 
No, you cannot be entered into any research study without further discussion and separate 
consent. After discussion, you may decide to take part in the research study. At that time, you 
will be asked to sign a specific research consent form. 
Treatment by your physician will not be affected by whether you provide authorization for the 
requested use or disclosure except if your treatment is related to research. 
 
8. What happens if I want to withdraw my permission? 
You can change your mind at any time and withdraw your permission to allow your protected 
health information to be used in the research. If this happens, you must withdraw your 
permission in writing.  Beginning on the date you withdraw your permission, no new protected 
health information will be used for research. However, researchers may continue to use the 
protected health information that was provided before you withdrew your permission.  If you 
sign this form and enter the research study, but later change your mind and withdraw your 
permission, you will be removed from the research study at that time. 
To withdraw your permission, please contact the person below. She will make sure your written 
request to withdraw your permission is processed correctly. 
 
Contact Name: Kimberly A. Davis, DrNP(c), CRNA 
Contact Address:  333 Cottman Avenue, Philadelphia, PA 
Contact Phone and  Pager, 215 308 1262; Phone 215 728 3180; FAX 215 214 1734 
 
9. How long will this permission last? 
If you agree by signing this form that researchers can use your protected health information, this 
permission has no expiration date. However, as stated above, you can change your mind and 
withdraw your permission at any time. 
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10. What are my rights regarding access to my personal health information? 
You have the right to refuse to sign this permission form. You have the right to review and/or 
copy records of your protected health information kept by Fox Chase Cancer Center 
 
****************************************************************************** 
 
Signatures 
I agree that my protected health information may be used for the research purposes described in 
this form. 
 
Participant Signature:         Date:     
or Legal Representative:        Date:      
Printed Name of Legal Representative (if any):        
 HIPPA CONSENT 
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Numeric Pain Rating Scale 
Located in the Fox Chase Cancer Center Employee Handbook   
Nursing Standards: Section 1 
https://myportal.fccc.edu/portal/c/document_library/get_file?groupId=11506&uuid=855a9c0f-
d46f-40df-b4fc-1b75434dbf25   
https://myportal.fccc.edu/portal/c/document_library/get_file?groupId=11506&uuid=3af5aeaa-
c39a-4cca-ab8f-6d6dffc60fb6   
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IRB #11-883                               Demographic Data Sheet 
      Please Circle ONLY ONE Answer:  
           
1. What is the highest level of Education you have completed?  
a. None 
b. Grade School 
c. GED 
d. High School Diploma 
e. Some College (Diploma or Associate Degree) 
f. Undergraduate Degree (Bachelor’s) 
g. Graduate Degree (Master’s/Doctorate) 
 
2. What is your current Marital Status? 
a. Single 
b. Married 
c. Widowed 
d. Divorced 
e. Other 
 
3. What is your Yearly Income? 
a. < $10,000 
b. < $20,000 
c. < $25,000 
d. < $50,000 
e. < $75,000 
f. < $100,000 
g. > $100,000 
 
4. What is your Race? 
a. Caucasian/White 
b. Black/African American 
c. Asian 
d. Latino/Hispanic 
e. Other 
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5. Do you suffer from Chronic Pain? 
a. No/Never 
b. Rarely 
c. Occasionally 
d. Yes/Sometimes 
e. Always 
 
6. If you have Chronic Pain, please rate your pain level now using the 0-10 score.  0 = No 
Pain and 10 = Worst Possible Pain.   
a. _____________ 
b. I Do Not have Chronic Pain 
 
7. Do you take Medications for Pain? 
a. Never 
b. Rarely 
c. Occasionally 
d. Weekly 
e. Daily 
f. Several Times Per Day 
 
8. What is your Age?  
a. _____________ 
 
9. Do you Smoke Cigarettes? 
a. Never 
b. Quit Smoking 
c. Occasionally 
d. Daily 
 
10. Do you Exercise 
a. Never 
b. Rarely 
c. Occasionally 
d. Regularly (several times per week) 
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11. What is your Natural Hair Color? 
a. Blonde 
b. Brunette 
c. Black 
d. Red/Auburn 
e. Other 
 
Please circle ALL that Apply: 
 
12. Emotional Support Through  
a. Family/Friends 
b. Meditation 
c. Prayer 
d. Acupuncture/Acupressure 
e. Massage Therapy 
f. Other__________ 
 
13. Spiritual Support Through 
a. Family/Friends 
b. Meditation 
c. Prayer 
d. Acupuncture/Acupressure 
e. Massage Therapy 
f. Other__________ 
 
14. I am NOT comfortable if 
a. I am too Cold 
b. I am too Hot 
c. I am Hungry 
d. My Activity is Limited 
e. I have Pain 
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Date_________________________    Code #_____________ 
 
GENERAL COMFORT QUESTIONNAIRE 
 
Thank you VERY MUCH for helping me in our study of the concept COMFORT.  Below are 
statements that may describe your comfort right now.  Six numbers are provided for each 
question; please circle the number you think most closely matches your feeling.  This is about 
your comfort at the moment you are answering the questions.  
  
                                                                                 Strongly      Strongly 
                                                                                 Disagree       Agree 
 
1. There are those I can depend on when I need help       1        2      3        4         5        6 
 
2. I don’t want to exercise                                                1        2      3        4         5        6 
 
3. My condition gets me down                                         1        2      3        4         5        6 
 
4. I feel confident                                                             1        2      3        4         5        6    
 
5. I feel my life is worthwhile right now                         1        2      3        4         5        6  
 
6. I am inspired by knowing that I am loved                   1        2      3        4         5        6  
 
7. The sounds keep me from resting                                1        2      3        4         5        6 
 
8. No one understands me                                                1        2      3        4         5        6  
 
9. My pain is difficult to endure                                       1        2      3        4         5        6  
 
10. I am unhappy when I am alone                                    1        2      3        4         5        6  
 
11. I do not like it here                                                       1        2      3        4         5        6  
 
12. I am constipated right now                                           1        2      3        4         5        6  
 
13. I do not feel healthy right now                                     1        2      3        4         5        6  
 
14. My room makes me feel scared                                   1        2      3        4         5        6  
 
15. I am afraid of what is next                                           1        2      3        4         5        6  
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16. I am very tired                                                            1        2      3        4         5        6  
                                                                               
17. I am content                                                                 1        2      3        4         5        6  
 
18. This chair (bed) makes me hurt                                  1        2      3        4         5        6  
 
19. The views are soothing                                              1        2      3        4         5        6  
 
20. My personal belongings are not here                         1        2      3        4         5        6 
 
21. I feel out of place here                                               1        2      3        4         5        6  
 
22.   My friends remember me with their  
cards and phone calls                                                    1        2      3        4         5        6 
 
23. I need to be better informed about my health            1        2      3        4         5        6  
 
24. I don’t have many choices                                         1        2      3        4         5        6 
 
25.   This room smells bad                                                  1        2      3        4         5        6 
 
26.   I feel peaceful                                                              1        2      3        4         5        6 
 
27. I am depressed                                                           1        2      3        4         5        6  
 
28. I have found meaning in my life                               1        2       3        4         5        6  
 
 
 
 
 
 
 
 
 
 
 
 
PAIN AND COMFORT AFTER PROSTATE SURGERY 77 
  
 
Appendix G 
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Drexel University Request for Letter of Reliance 
 
July 9, 2012 
 
To Whom It May Concern: 
 
          This letter is a Request for a Reliance Agreement between Fox Chase Cancer Center and 
Drexel University.  The Primary Investigator, Kimberly A. Davis, DrNP(c), CRNA is currently 
employed at Fox Chase Cancer Center as a Nurse Anesthetist and in a Doctoral Program at 
Drexel University for DrNP completion.  This program requires research for completion.  
Final IRB approval for IRB# 11-883 Fox Chase Cancer Center occurred June 8, 2012.  
Research entitled “Pain Management and Comfort in Robotic Laparoscopic Prostatectomy 
Patients”.  There is no funding for this research.    
Key personnel at Drexel University consist of Kimberly A. Davis, DrNP(c), CRNA, 
Primary Investigator (Student in DrNP program).  Linda Wilson, PhD is my Supervising 
Professor / Research Advisor.  Linda Wilson, PhD, RN, CPAN, CAPA, BC, CNE, Assistant 
Dean for Special Projects, Simulation & CNE Accreditation, Associate Professor, College of 
nursing and Health Professions.  Dr. Wilson will provide guidance throughout research project to 
graduation.   
Drexel University IRB Authorization Agreement may be signed by Mr. Jack Medendorp, 
MS, BSN, CIP, Assistant Director for Research Compliance at Drexel University contact 
information phone # 215 255 7859 e-mail: Jcm29@drexel.edu   Drexel University’s IRB FWA# 
will be provided upon completion of the actual agreement by Drexel University.   
 
Thank you for your consideration and time. 
 
Sincerely,  
 
Kimberly A. Davis, DrNP(c), CRNA 
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Certificate of Completion 
This is to acknowledge that 
Kimberly Davis 
certified in the Human Subjects Protection 
Program at Fox Chase Cancer Center on 
10/08/2012 
_____________________Jane Nice __________________________ 
IRB Staff, Office of the Institutional Review Board 
NCI 
CITI Program 
Seminar 
CITI COI 
Other: _ _ 
Expiration Date: 10/07/2015 
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IRB#: 11-883 PI: Kimberly Davis Date: 12/12/13 
Title:  Pain Management and Comfort in Robotic Laparoscopic Prostatectomy Patients                          
 
                                                                                           
Grant # (if applicable): NONE  
 
Study expiration date (per Initial or Continuing Review Approval Notice) 01/09/2014 
Please answer the following questions. Attach additional pages as necessary. 
 
1. Summarize any revisions to the protocol or informed consent document/HIPAA 
Authorization previously reviewed and approved in the attached activity report (see page 4.) 
NO REVISIONS 
         
2. Are there any pending revisions that have not yet been reviewed and approved by the IRB? 
Please check one:  No  Yes 
 
3. Have there been any changes to the risks and/or benefits based on the results obtained from 
the study? 
Please check one.    No   Yes: please discuss:      
 
(If you answered yes, please discuss whether 1) changes have been previously incorporated into 
the informed consent document, 2) have been submitted to the IRB as a study amendment and 
are presently under review or, 3) are not required). 
 
4. Have unexpected events, toxicity or complications occurred?  Does the protocol or informed 
consent document need to be changed?    
Please check one.    No   Yes: please discuss:      
 
5. Has information (publications, presentations, etc.) become available since starting this study 
that indicates a need to modify the study (protocol or consent)?  
Please check one.   No  Yes: please discuss:      
 
6.   Have there been any grievances or complaints received from study participants about this 
study? 
      Please check one.   No   Yes: please discuss:      
 
 
Continuing 
Review 
Institutional Review Board 
50 Huntingdon Pike, 2nd floor 
Rockledge, PA 19046 
Phone#: 215-214-3754 
Fax#: 215-214-4256 
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7.  Do you or any other person responsible for the design, conduct, or reporting of this research 
have  a financial or other conflict of interest as defined by the Institution or IRB Conflict of 
Interest Policy that would affect this research and has not previously been disclosed?   
 Please check one.    No     Yes: please discuss:         
    IRB# 11-883                                              
 
8. Has the study been closed to participant accrual since the date of the initial approval or 
last continuing review? 
  No  Yes:    Date: 2/8/2013       Reason: Both Groups Were Filled  
 
9. Briefly summarize the research results/findings to date, including the progress of the 
study as compared to the hypothesis (if the study is a multi-center study, please describe or 
attach the reports from the other sites or the study sponsor). 
 
      I am in the process of statistical calculations to determine if there is any variation between 
Group A & Group B and/or the relationship between pain and comfort in the postoperative 
setting of this group. 
 
Specific Aim 1 is to explore the effect of 2 groups of pharmaceutical regimens on pain and 
comfort in the laparoscopic robotic prostatectomy patient.  The null hypothesis:  Pain and 
comfort will not vary among the two pharmaceutical regimens.  
Group A:  Opioids  
Group B:  Opioids + α 2 agonist 
 
Specific Aim 2:  The specific aim 2 is to explore the relationship between pain and comfort in 
post-operative RALP patient.  The null hypothesis:  Decreased pain will not be associated with 
increased comfort 
Recruitment of Subjects:  (check all that apply): 
 
 Physician Referrals 
 Clinic 
 Calls to CIS 
 Advertising 
 Website 
 Other (explain) 
 Recruitment through Urology department when scheduled for RALP procedure        
 
Signature of PI: ____Kimberly A. Davis, DrNP(c), CRNA____________ Date: 12/12/13 
Checklist to Include with this Form: 
X Application for Continuing Review (including Review Request, Activity Report and Reviewer 
Evaluation, one copy of newest protocol including all changes) 
X   Electronic Copy of currently approved Informed Consent Document/HIPAA 
N/A   Data Safety Monitoring Report (if applicable) 
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IRB #11-883 
Review Request 
Study Objectives: ==ACCRUAL== 
                                                                    Projected Actual 
Total (All Sites) 46 48 
Total (FCCC & Network) 46 48 
Total (FCCC Only) 46 48 
Annual *(FCCC Only)             
Months active overall 1-3 5 
Months active from last IRB 2 2 
Withdrawals** 0 0 
*Note: Actual annual accrual tabulated from last IRB review date  
**If applicable list reasons for withdrawal on activity report 
 
Comments:  There are no additional treatment-related toxicities or safety issues with an impact on 
study  
            Additional treatment-related toxicities and/or safety issues are attached. 
   Protocol and/or informed consent changes are attached. 
   This is an NCI-sponsored national cooperative group trial with anticipated low accrual.  
   Prioritization is reviewed at semi-annual group meetings. 
Protocol data reviewed by:    Print Name:      
PI Request:  Renew for active patient accrual. 
   Study is currently suspended, renew for patient accrual if re-activated by sponsor. 
  Renew. Study is closed to new accrual but remains active for treatment and/or follow-up 
of enrolled participants or data analysis - continuing review required. 
   Study approved but not yet activated – continuing review required. 
   Do not renew.  Protocol terminated. 
Principal Investigator: Kimberly A. Davis, DrNP(c), CRNA Print Name: Kimberly A. Davis, DrNP(c), CRNA 
 
 
DO NOT WRITE BELOW THIS LINE 
RRC Action: IRB Action: 
 Approved for active patient accrual (12 months)  Approved for active patient accrual (12 months) 
 Approved for active patient accrual (6 months) with warning  Approved for active patient accrual (6 months) with 
warning 
 Approved for continuing patient evaluation, closed to active accrual  Approved for continuing patient evaluation, no 
active accrual 
 Approved for continuing review but not yet opened  Approved for continuing review but not yet opened 
 Protocol terminated  Protocol terminated 
 Tabled pending investigator response  Tabled pending investigator response 
 
Chairperson: 
  Chairperson:
  
 Date: 
  Date:
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IRB #11-883 
Activity Report 
 
Review/Approval and Activity* 1     
Date Activity* Comments 
      
 
            
            
 
      
            
 
      
            
 
      
            
 
      
            
 
      
            
 
      
            
 
      
            
 
      
            
 
      
            
 
      
            
 
      
            
 
      
 
 *Activities include amendments, withdrawals1 and reasons, adverse events, unanticipated problems or outcomes, 
changes to the consent form, suspensions, closures and terminations.  
1 Include subjects withdrawn from the study or been withdrawn from the study by the investigator 
 
USE ADDITIONAL PAGES AS NECESSARY 
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IRB #11-883 
 
Summary of Accrual (FCCC Only) 
     
Subject ID** Sex Race Start Date 
End Date 
Date of Death 
                              
      
 
                        
      
 
                        
      
 
                        
      
 
                        
      
 
                        
      
 
                        
      
 
                        
      
 
                        
      
 
                        
      
 
                        
      
 
 
                        
                              
 
**Subject ID should be a code, rather than subject identifiable information. 
 
USE ADDITIONAL PAGES AS NECESSARY 
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IRB #11-883 
*******************DO NOT WRITE BELOW THIS LINE********FOR IRB USE ONLY ************* 
Risk/Benefit Assessment 
RISK 
Regulatory definition of minimal risk:  Minimal risk means that the probability and magnitude of harm or 
discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily 
life or during the performance of routine physical or psychological examinations or tests (45 CFR 46.102(h)(I)). 
Check appropriate risk category: 
1. __________ The research involves no more than minimal risk to subjects. 
2. __________ The research involves more than minimal risk to subjects. 
a. __________ The risk(s) represents a minor increase over minimal risk, or 
b. __________ The risk(s) represents more than a minor increase over minimal risk. 
BENEFIT 
Definition:  A research benefit is considered to be something of health-related, psychosocial, or other value to an 
individual research subject, or something that will contribute to the acquisition of generalizable knowledge.  Money 
or other compensation for participation in research is not considered to be a benefit, but rather compensation for 
research-related inconveniences. 
Check appropriate benefit category: 
1. __________ The research involves no prospect of direct benefit to individual subjects, but is likely to yield 
generalizable knowledge about the subject's disorder or condition. 
2. __________ The research involves the prospect of direct benefit to individual subjects. 
*I verify that the regulatory criteria for approval of research have been met.     
 
Reviewer Name:_________________________________*Signature: ____________________________________ 
 
Regulatory Review Requirement Reviewed Suggested Questions for IRB 
Risk to subjects are reasonable in relation to anticipated 
benefits, if any, to subjects, and the importance of 
knowledge that may be reasonably expected to result. 
  
Frequency and extent of continuing review.  Is there sufficient risk to warrant review of this protocol 
sooner than the standard 365 days? 
Confirmation of use of approved protocol.  Have all changes in the protocol to be reviewed already 
been reviewed and approved by the IRB? 
Confirmation of use of approved consent form. 
 
 
 
 
 
Is the consent form appropriately reflective of the protocol? 
Is there a need to request confirmation from someone other 
than the PI that no changes have been made to the protocol 
other than those previously reviewed and approved by the 
IRB?Is the current consent still accurate and complete? 
Review of progress of the study.  What progress has been made? What changes to the 
protocol have been necessitated? What have been the 
experiences of the subjects (adverse events and benefits)? 
Confirmation that the study is conducted in accordance with 
appropriate guidelines and regulations. 
 Is this study being conducted in accordance with IRB 
policies and procedures? 
Discussion of findings to date of this study or existing 
literature. 
 Has any new information been discovered that may affect a 
subject’s decision to participate or continue to participate? 
If so, how has this information been communicated to 
currently accrued subjects? 
Terminated study review and notification of subjects.  Have all subjects been notified that the study has been 
terminated? If so, by what method? 
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Authorization (Permission) to Use or Disclose (Release) Protected 
Health Information (PHI) for Research 
 
IRB# and Protocol ID: IRB #11-883  
Study Title:  Pain Management and Comfort in Robotic Laparoscopic 
Prostatectomy Patients 
Principal Investigator: Kimberly A. Davis, DrNP(c), CRNA 
Coordinating Group 
(or Center): 
Fox Chase Cancer Center 
Other Sponsor(s): Drexel University 
2. What is the purpose of this form? 
This form is required by the Health Insurance Portability and Accountability Act of 1996.  Specifically 
the privacy regulation (HIPAA) permits the research investigators listed above to use and disclose health 
information about you for the research study identified above which has been approved by the Fox Chase 
Cancer Center Institutional Review Board. 
The Fox Chase Cancer Center is an organization that does research to learn about the causes of cancer, 
and how to prevent and treat cancer. Researchers would like to use your protected health information for 
research. The elements of protected health information as defined by HIPAA are: 
 
Data Elements for Protected Health Information (PHI) 
• Names 
• All geographic subdivisions smaller than a state (except for the first 3 digits of the zip code in 
some cases) 
• All elements of dates (except year) for dates directly related to an individual (e.g., birth date, 
admission date, discharge date, date of death) and all ages over age 89 and dates indicative of that 
age 
• Telephone numbers 
• Fax numbers 
• E-mail addresses 
• Social security numbers 
• Medical record numbers 
• Health plan beneficiary numbers 
• Account numbers 
• Certificate/license numbers 
• Vehicle identifiers and serial numbers, including license plate numbers 
• Device identifiers and serial numbers 
• Web Universal Resource Locators (URL) 
• Internet Protocol (IP) addresses 
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• Biometric identifiers, including finger and voice prints 
• Full face photos and any comparable images 
• Any other unique identifying number, characteristic, or code 
 
2. What protected health information do the researchers want to use? 
The researchers may want to copy and use the portions of your health information that they will need for 
their research. If you enter a research study, health information that maybe used and/or released include 
the following: 
• Personal medical history; 
• Family medical history; 
• Tissue/blood/cells/DNA; 
• Content of audio/video recording of sessions; 
• Current and past cancer screening and lifestyle practices, medications, therapies, 
diagnostic tests, surgeries, and/or biopsies; 
• Information from a genetic test you may have had in the past (for example, BRCA1 
and/or BRCA2 testing) 
• Any information collected in the Health History Questionnaire and/or other survey 
instruments completed during the course of the study. 
 
You may request a blank copy of the data forms from the study doctor or his/her research staff to learn 
what information will be shared. 
3. Why do the researchers want my protected health information? 
Fox Chase Cancer Center will collect your protected health information and share it with the Fox Chase 
Cancer Center Biostatistical Center if you enter a research study. The center will use your information in 
their cancer research study. 
4. Who will be able to use my protected health information? 
Fox Chase Cancer Center will use your health information for research. As part of this research, it may 
give your information to the following groups taking part in the research. Fox Chase Cancer Center may 
also permit these groups to come in to review your original records that are kept by Fox Chase Cancer 
Center so that they can monitor the research study. 
• The Fox Chase Cancer Center Biostatistical Center 
• Public health agencies and other government agencies (including non-U.S.) as authorized or 
required by law; 
• Other people or organizations assisting with research efforts of the Fox Chase Cancer Center 
5. How will information about me be kept private? 
Fox Chase Cancer Center will keep all health information private to the extent possible. Only researchers 
working with Fox Chase Cancer Center or the sponsor will have access to your information. Fox Chase 
Cancer Center or the sponsor will not release personal health information about you to others except as 
authorized or required by law. However, once your information is given to other organizations that are not 
required to follow federal privacy laws, we cannot assure that the information will remain protected. 
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6. What happens if I do not sign this permission form? 
If you do not sign this permission form, you will not be able to take part in the research study for which 
you are being considered. 
 
7. If I sign this form, will I automatically be entered into the research study? 
No, you cannot be entered into any research study without further discussion and separate consent. After 
discussion, you may decide to take part in the research study. At that time, you will be asked to sign a 
specific research consent form. 
Treatment by your physician will not be affected by whether you provide authorization for the requested 
use or disclosure except if your treatment is related to research. 
 
8. What happens if I want to withdraw my permission? 
You can change your mind at any time and withdraw your permission to allow your protected health 
information to be used in the research. If this happens, you must withdraw your permission in writing.  
Beginning on the date you withdraw your permission, no new protected health information will be used 
for research. However, researchers may continue to use the protected health information that was 
provided before you withdrew your permission.  If you sign this form and enter the research study, but 
later change your mind and withdraw your permission, you will be removed from the research study at 
that time. 
 
To withdraw your permission, please contact the person below. She will make sure your written request to 
withdraw your permission is processed correctly. 
Contact Name: Kimberly A. Davis, DrNP(c), CRNA 
Contact Address:  333 Cottman Avenue, Philadelphia, PA 
Contact Phone and FAX: Pager, 215 308 1262; Phone 215 728 3180; FAX 215 214 1734 
 
9. How long will this permission last? 
If you agree by signing this form that researchers can use your protected health information, this 
permission has no expiration date. However, as stated above, you can change your mind and withdraw 
your permission at any time. 
 
10. What are my rights regarding access to my personal health 
information? 
You have the right to refuse to sign this permission form. You have the right to review and/or copy 
records of your protected health information kept by Fox Chase Cancer Center.  
 
************************************************************************************ 
Signatures 
I agree that my protected health information may be used for the research purposes described in this form. 
 
Participant Signature:         Date:     
or Legal Representative:        Date:      
Printed Name of Legal Representative (if any):          
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INFORMED CONSENT DOCUMENT 
 
Pain Management and Comfort in Robotic Laparoscopic Prostatectomy Patients 
 
Principal Investigator:  Kimberly A. Davis, DrNP(c) CRNA 
 
This is a clinical trial, a type of research study.  Your study nurse will explain the clinical trial to 
you.  Clinical trials include only people who choose to take part.  Please take your time to make 
your decision about taking part.  You should discuss your decision with your friends and family.  
You will also discuss it with your health care team.  If you have any questions, you can ask your 
study nurse for more explanation.   
You are being asked to take part in this research study because you have Prostate Cancer and 
have chosen Robotic Laparoscopic Prostatectomy surgery. 
The sponsor of this study is Fox Chase Cancer Center. 
 
Why is this research study being done? 
The purpose of this study is to find out the best pain management strategy after your procedure.  
We would like to find out what combination of medications work best after your surgery.  You 
will receive the same care and medications chosen by your anesthesia provider whether or not 
you participate in this study.  These medications will be reviewed after your surgery is complete 
and compared to your pain score. We do not know if you will benefit from this research study.  
We can use what we learn from this research study to help other people with the same disease. 
 
How many people will take part in this research study? 
About 23 people for each group (two groups) will be needed for this research.  A total of 46 
people will take part in this research study if able to fill groups evenly.   
 
What will happen if you take part in this research study? 
Before you begin the research study... You will be given a Demographic Data Sheet to complete.  
Prior to surgery, The Numerical Rating Scale (NRS) and Comfort Questionnaire will be 
completed.  Postoperatively, upon arrival to the Recovery Room (Post Anesthesia Care Unit 
PACU) and at PACU discharge, the NRS will be administered.  The Numerical Rating Scale will 
be completed in the recovery area by the PACU RN.  Upon PACU discharge to medical/surgical 
room, the Numerical Rating Scale and Comfort Questionnaire will be completed.  Evaluation of 
medical record will provide medications received intraoperatively.  This will place participant in 
Group A or B.  Further medications will be recorded from PACU setting.       
 
No tests or procedures will be required to participate in this study.  
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During the research study... 
 
If you choose to take part in this research study, then you will be asked to participate in 
answering the Comfort Questionnaire information.   The Numerical Rating Scale and 
medications provided during your care are part of regular cancer treatment.  
 
• Comfort Questionnaire 
 
You will receive the Numerical Rating Scale as a part of regular cancer care.  This is being done 
no different because you are in this research study.  
 
• Numerical Rating Scale  
 
You will need no tests or procedures for this research study.  Your chart will be reviewed after 
your surgery to determine what medications you received and review your Numerical Rating 
Scale Scores.   
 
• Medication Review for group placement  
 
Questionnaires 
 
We are asking you to fill out a Demographic Data Form which is a Questionnaire that will be 
filled out one time only and takes < 5 minutes for completion.   
 
We are asking you to fill out questionnaires about comfort for this research study.  This 
questionnaire will tell us about your pain and your comfort.  You will spend 10-15 minutes to fill 
out the comfort questionnaire.  We will ask you to fill this out before your surgery one time and 
one time after your surgery to total two times during this research study. 
 
You do not have to answer any questions that make you uneasy.  Whether or not you answer any 
question will not affect your medical care.  We will keep the paper copies of the questionnaires 
in a locked file to protect your privacy.   
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Study Chart  
      
You will receive a questionnaire one time before your surgery and one time after your 
surgery describing your comfort for this research study. This [two questionnaires from 
before your surgery until you return to your room] is called a cycle in the research time 
frame.  The cycle will be not be repeated.  The chart below shows what will happen to you 
during your participation in this research.  The left-hand column shows the day in the cycle 
and the right-hand column tells you what to do on that day. 
 
 
 
Cycle 1 
Day  What you do 
Prior to Surgery 
Admission 
• Fill out Demographic Data Sheet, Numeric Rating Scale for pain 
& General Comfort Questionnaire (16-21 minutes total time). 
Day of Surgery  
• Report for Surgery, Fill out Numeric Rating Scale (1 minute total 
time).   
Recovery Room • Numeric Rating Scale (1 minute total time) completed in PACU. 
Admission to 
Room 
• Numeric Rating Scale & General Comfort Questionnaire (11-16 
minutes total time). 
Research after  
Admission to 
Room  
• Researcher will Review Data for Medications Received & gather 
information Numeric Rating Scale from medical record. 
Conclusion • No further information or Questionnaires Required. 
 
 
Future cycles 
Day What you do 
Days 1-28 
• No further information required.  Continue with surgical treatment 
plan as indicated by your surgeon. 
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Study Plan  
 
Another way to find out what will happen to you during the research study is to read the chart 
below. Start reading at the top and read down the list, following the lines and arrows.  
 
Before your Surgery (16-21  minutes) 
Fill out Questionnaires 
 
Day of Surgery (13-18 minutes) 
Fill out Questionnaires 
 
 
Medicines used in this study 
This study will not change your medications received.  You will receive standard of care 
throughout your hospitalization.   
 
 
Appendix H 
 
Group A:  
 
Opioids  
 
 
    
  
Group B:  
 
Opioids + α 2 agonist 
                         
 
 
  
 
How long will you be in the research study? 
The research study will be complete after you have been admitted to your Room and have 
completed the final Numeric Rating Scale & General Comfort Questionnaire.  Since there is no 
change in your care during this research, no follow up will be required.  You will continue 
follow up with your surgeon as directed.   
 
Review Medical Record After 
Information Collected to place into one 
of 2 groups (A & B) depending on 
medications received.* 
(You will be in one of two Groups)  
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Can you stop being in the research study? 
Yes.  You can decide to stop at any time.  Tell the study coordinator if you are thinking about 
stopping or decide to stop.  He or she will tell you how to stop safely.  
 
It is important to tell the study coordinator if you are thinking about stopping so any risks can be 
evaluated as needed.  Another reason to tell your research coordinator that you are thinking about 
stopping is to discuss what followup care could be most helpful for you. 
 
Can you be removed from this research study? 
The study nurse may stop you from taking part in this research study at any time if he/she 
believes it is in your best interest; if you do not follow the research study rules; or if the research 
study is stopped. 
 
What side effects or risks can you expect from being in the research study? 
The study introduces little risk for subjects.  Your medical record review will reveal which group 
you will be placed into only after your care is complete.  You will not receive any specific 
medications while taking part in this research.  You will not require any blood work or testing as 
a result of participation in this research.  You should talk to your study nurse about any issues 
that you may have while taking part in the research study.  
 
Are there benefits to taking part in the study? 
Taking part in this study may or may not make your health better.  While your healthcare 
providers administer high quality care with monitored comfort and pain control, it would be 
more useful to compare the variety of treatment modalities.  This study may provide information 
determining a best pain management strategy for this robotic laparoscopic procedure, both 
improving pain control and comfort for a quick recovery and expedited discharge from the 
hospital.  Although there is no proof of this yet, we do know that the information from this study 
will help your healthcare team learn more about improving pain control and comfort for this 
specific type of surgery.  This information could help future cancer patients. 
 
What other choices do you have if you do not take part in this research study? 
Your other choices may include: 
• Getting treatment or care for your cancer without being in a study  
• Taking part in another study  
• Getting no treatment  
Talk to your doctor about your choices before you decide if you will take part in this study. 
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Will your medical information be kept private?  
We will do our best to make sure that the personal information in your medical record will be 
kept private.  However, we cannot guarantee total privacy.  Your personal information may be 
given out if required by law.  If information from this study is published or presented at scientific 
meetings, your name and other personal information will not be used.  
 
Organizations that may look at and/or copy your medical records for research, quality assurance, 
and data analysis include: 
 
• Fox Chase Cancer Center, Institutional Review Board 
• The National Cancer Institute (NCI) and other government agencies, like the Food and 
Drug Administration (FDA), involved in keeping research safe for people  
 
You will be given a separate form to review regarding the steps we will take to guard your 
privacy as part of your participation in the research study.  By signing that additional 
authorization, you will be providing your consent to use and disclose information described in 
that form connected with your participation in this research study. 
 
What are the costs? 
Taking part in this study may or may not cost your insurance company more than the cost of 
getting regular cancer treatment. 
 
Will you be compensated? 
You will not get paid for taking part in this research study.  If you are harmed because of the 
research study, we will provide the medical care to treat that harm.  However, you may have to 
pay for this treatment.  Fox Chase Cancer Center has not set aside funds to pay your salary if you 
cannot work or for any other damages if you are harmed because of the research study.   
 
What are your rights if you take part in this research study? 
Taking part in this research study is your choice.  You may choose either to take part or not to 
take part in the research study.  If you decide to take part in this study, you may leave the study 
at any time.  No matter what decision you make, there will be no penalty to you and you will not 
lose any of your regular benefits.  Leaving the study will not affect your medical care.  You can 
still get your medical care from our institution.  
In the case of injury resulting from this study, you do not lose any of your legal rights to seek 
payment by signing this form.  
 
New findings 
 
We will tell you about new information or changes in the study that may affect your health or 
your willingness to continue in the study. 
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Who can answer your questions about the research study? 
 
If you have questions about: Please Page: 
This study Kimberly A. Davis, DrNP(c), CRNA  
215-308-1262 
If you get sick or hurt in this study Kimberly A. Davis, DrNP(c), CRNA  
215-308-1262 
If you have a concern or complaint Director, Risk Management 
215-728-2591 
Your rights as a research participant while 
you are on this study or after the study ends 
Institutional Review Board 
215-214-3754 
Your bills or health insurance coverage Clinical Trial Financial Counselor 
215-214-1727 
 
Where can you get more information? 
 
You may call the National Cancer Institute's Cancer Information Service at:  
 
1-800-4-CANCER (1-800-422-6237) or TTY: 1-800-332-8615 
 
• You may also visit the NCI website at http://cancer.gov 
• For NCI's clinical trials information, go to: http://cancer.govclinicaltrials/  
• For NCI's general information about cancer, go to: http://cancer.gov/cancerinfo/  
 
By signing below, you tell us that you have received all of the information you need; that you 
have clear answers to your questions, and that you agree to take part in the research study.  You 
will receive a copy of this form.  You may also request a copy of the research plan.  
 
_____________________________________  ________________________ 
Signature of Participant     Date 
 
_________________________________________ _________________________ 
Signature of Person Obtaining Consent,   Date 
Degree  
 
By signing this form the Private Investigator obtaining consent indicates that the research 
participant has been fully informed of all aspects of the research study. 
 
 
Informed Consent Document Template for Clinical Trials 10/2009 
 
PAIN AND COMFORT AFTER PROSTATE SURGERY 102 
  
 
Appendix H (continued) 
 
 
 
                                                               
Recruitment 
Consent/Assent 
IRB#: 11-883 
PI: Kimberly A. Davis, DrNP(c)  
 
Date:  1/27/2012 
 
Title: Pain Management and Comfort in Robotic Laparoscopic Prostatectomy Patients 
 
 
Resources 
1. Do you have the resources (i.e. adequate facilities, staff, availability of psychological resources) you 
need to complete this study?    Yes     No    If no, please explain 
______________________________________________________ 
 
Approach and Recruitment Procedures 
1. When will the participants be approached? (check all that apply) 
   Prior to coming to FCCC for clinic visit   During Admission 
   At clinic visit/In clinic   After discharge or clinic visit 
   Other (explain) _________________________________________________________________ 
 
2. How will the participants be approached? (check all that apply) 
  Phone          Mail/letter          Personal Contact          Other (explain) ________________ 
 
3. Who will initiate contact about the study with the participants? (check all that apply) 
  PI   Kimberly A. Davis, DrNP(c), CRNA      Recruitment Specialist      Research coordinator           
Other (please list by title) 
Rosalia Viterbo, MD, FACS 
Robert G Uzzo, MD, FACS 
Richard E Greenberg, MD, 
FACS 
David Y T Chen, MD, 
FACS 
Alexander Kutikov, MD 
 
 
4. Do you intend to enroll any research participants from the following “vulnerable” categories?  *If 
yes, describe additional safeguards that are included in the protocol to insure the safety and welfare 
of these vulnerable populations.  
  *YES  NO 
  Prisoners      Minors (under 18 years of age)      Pregnant woman (If yes, you must complete 
question 4a) 
  Decisionally Impaired (If checked, complete below) 
  If some or all subjects will be decisionally impaired, describe how capacity for consent will be 
determined: 
 
Recruitment 
Consent/Assent 
Process Information 
Form 
Institutional Review Board 
50 Huntingdon Pike, 2nd floor 
Rockledge, PA 19046 
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  Capacity Assessment by: _______________________________________________________________ 
   Other (specify 
______________________________________________________________________ 
               Will a legally authorized representative be utilized?   *YES  NO      
  Describe Additional safeguards: 
_____________________________________________________________ 
      
_______________________________________________________________________________________ 
  Students to be recruited in their educational setting, i.e. in class or at school 
  Employees, student, or volunteers directly supervised by PI or sub-investigator 
  Employees of Research Site or Sponsor 
  Others Vulnerable to Coercion (Specify) __________________________________________________ 
 
4a. If you plan to enroll pregnant women, complete the following:      N/A 
 As required by Federal Regulations, I assure the Board of the following:  (45 CFR 46.204 (h), (i), (j)) 
• No inducements, monetary or otherwise, will be offered to terminate a pregnancy; 
• Individuals engaged in the research will have no part in any decisions as to the timing, method, or 
procedures used to terminate a pregnancy, and 
• Individuals engaged in the research will have no part in determining the viability of a neonate. 
 
_____________________________  __________________ 
 
 
Signature of PI    Date 
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)  Date 
 
                                                                               
 
IRB #11-883 
5. Approximate ethnic makeup of population to be recruited for this research: 
 ___25% African-American     ____4% Asian     _____% Pacific Islander     ____10% Middle Eastern        
              ___68% Caucasian ____3% Hispanic     _____% Native American/First Nations      
              _____%  Other:  _____________________ 
6. Check any of the following methods that the PI will use to recruit research participants for this 
study: 
  Advertising (All recruitment materials must be approved by FCCC IRB before use) 
  From a database for which research participants have given prior permission to be contacted for 
research studies 
  From personal contact (e.g., patients, students) 
  Referrals (referral fees are not allowed by FCCC IRB) 
  Phone script 
  Other (specify): ____________________________________________ 
PLEASE NOTE – for HIPAA compliance, you may need an authorization from the research participant or a waiver of 
authorization before you can use or disclose identifiable health information for research screening or recruitment purposes.  This 
may affect your ability to recruit research participants into this study.  For more information on HIPAA requirements for research 
and additional HIPAA-related forms, http://www.fccc.edu/research/institutional_review/index.html 
 
Consent/Assent Procedures 
7. FCCC IRB expects that the research participant consent process will be conducted under the 
following conditions: 
• Will take place without undue influence or coercion.  
• Will allow the research participants adequate time to consider the research before signing. 
• Will be conducted in a private place and manner. 
• Will be conducted with words understandable to research participants. 
• The person obtaining consent will invite questions from the research participants. 
• The research participant will be allowed to take home an unsigned copy of the informed consent 
document to share with family and friends prior to enrollment. 
• The research participant will be given a signed and dated copy of the informed consent document 
for their records if enrolled. 
• Non-English speaking research participants will be provided with a certified translation of the 
approved informed consent document in the research participant’s first language.  The translation 
must be approved by FCCC IRB. 
Indicate one of the following and attach written explanation where instructed: 
 The consent process will meet all of the above conditions. 
 N/A, waiver of consent requested. 
 The consent process will not satisfy all of the above conditions, as it will take place in emergency 
situations; a written explanation of the proposed consent process is attached. 
 NOTE:  Please contact FCCC IRB for an explanation of submission requirements. 
 The consent process will not satisfy all of the above conditions, and the consent will not be 
obtained in an emergency situation.  A written explanation of the proposed consent process 
and the reason one or more conditions cannot be met is attached (for example, research 
participants are to be recruited in an outdoor public setting where a private consent discussion is not 
practicable). 
 
 
 
Recruitment 
Consent/Assent 
Process 
Information Form 
Institutional Review Board 
50 Huntingdon Pike, 2nd floor 
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IRB #11-883 
 
8. If any of your research participants do not speak English, explain how the person obtaining consent 
will communicate with the participant in a language understandable to the research 
participants/parents/legally authorized representatives? 
 a.  All research participants speak and read English 
 b.  Some of my research participants may not speak and/or read English (informed consent must be in 
the language of the participant) 
 If box (b.) is checked, explain how informed consent will be obtained for Non-English speakers. 
    Translated Informed Consent Document (Translator name, if 
known______________________) 
    Short Form with verbal presentation in language of participant 
 
9. In addition to the informed consent document, what else do you do to confirm the participant’s or 
guardian(s) understanding of the research? (Check all that apply) 
  Provide brochure  Conference with an interpreter 
  Conference with patient and family member  Arrange time for follow-up discussion 
  Other (describe): ___________________________________________________________________ 
 
 
For Social Sciences Studies Only 
 
10. Is any deception (withholding of complete information) required for the validity of this activity?   
   *YES   NO 
 *If yes, please explain why it is necessary and provide a copy of the debriefing procedure to be used at the 
conclusion of the study. 
 ______________________________________________________________________________________
__________________________________________________________________________________ 
 
 
Principal Investigator: __Kimberly A. Davis, DrNP(c) ______________________ 
   (PRINT NAME) 
 
   _________________________________________________Date: __________ 
   (SIGNATURE) 
 
 
 
 
 
Recruitment 
Consent/Assent 
Process Information 
Form 
Institutional Review Board 
50 Huntingdon Pike, 2nd floor 
Rockledge, PA 19046 
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Institutional Review Board 
Federal Wide Assurance #00003846 
 
MODIFICATIONS REQUIRED TO SECURE APPROVAL 
 
January 15, 2014 
Kimberly Davis, DrNP, CRNP 
 
Dear Kimberly: 
 
On January 15, 2014 the IRB reviewed the following protocol: 
Type of Review: Modification 
Title: Pain Management and Comfort in Robotic 
Laparoscopic Prostatectomy Patients 
Investigator: Kimberly Davis, DrNP, CRNP 
IRB ID: 11-883 
Funding: Fox Chase Cancer Center 
Grant Title: None 
Grant ID: None 
IND, IDE or HDE: None 
Documents Reviewed: Continuing Review Application/RRC Approval 
Protocol Version 2.0 dated 06/06/2012 
The IRB determined that modifications are required to approve the protocol. The modifications 
required and their reasons are listed here: 
Required Change Reason for Change 
• Within the protocol it states that 
there will be 46 participants in 
this study but within the 
continuing review application 
there are 48 participants 
reflected. A Protocol Violation 
form will need to be completed 
and submitted to explain the 
over enrollment. An amendment 
will also need to be completed 
and submitted increasing the 
accrual numbers. 
• The projected accrual number 
exceeded by 2 participants.  
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Please submit: 
• A letter with a point-by-point response to the above changes indicating whether you agree or 
do not agree with each requested change. 
• A copy of all revised documents in “Tracked Changes” format or similarly notated to 
indicate what changes were made. 
• A “clean” copy of all revised and requested additional documents. 
If a response is not received by close of business on February 15, 2014 the IRB will withdraw 
this offer. 
Should you disagree with these requested changes, your response will be reviewed by the IRB.  
At your request, you can respond in person to the IRB. 
Sincerely, 
IRB Vice-Chairperson/Eric Tetzlaff, PA-C 
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Kimberly A. Davis, DrNP(c), CRNA 
Fox Chase Cancer Center:  IRB  11-883 
January 16, 2014 
Pain Management and Comfort in Robotic Laparoscopic Prostatectomy Patients 
Point-by-point response to changes for protocol 
Required Change Reason for Change 
• Within the protocol it states that 
there will be 46 participants in this 
study but within the continuing 
review application there are 48 
participants reflected. A Protocol 
Violation form will need to be 
completed and submitted to 
explain the over enrollment. An 
amendment will also need to be 
completed and submitted 
increasing the accrual numbers. 
• The projected accrual number 
exceeded by 2 participants.  
 
 
 
I will make any necessary changes but did not realize that this was required since both groups were not 
full and it took 2 extra participants to fill both groups evenly (it was random and could have taken many 
more).  As per my protocol page 12 states that collection shall continue until both groups are filled.  The 
46 was a minimum number if evenly filled.  I have copied and pasted this sentence below for further 
review, in addition to showing the two groups.   
9.0.3  
Determination of Sample Size for two groups 
Group A:  Opioids 
Group B:  Opioids + α 2 agonist 
Recruitment will continue until both groups A & B of 23 per group are filled.  This will assume 15% 
attrition.     
With the above statement in the protocol, I do not agree that a violation is in effect, however; if the IRB 
feels that this has violated the protocol, I will fill out the necessary changes and submit.    
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Updated Consent with Temple Logo 
 
 
INFORMED CONSENT DOCUMENT 
 
Pain Management and Comfort in Robotic Laparoscopic Prostatectomy Patients 
 
 
Principal Investigator:  Kimberly A. Davis, DrNP(c) CRNA 
 
 
This is a research study.  Your study nurse will explain the study to you.  Research studies 
include only people who choose to take part.  Please take your time to make your decision 
about taking part.  You should discuss your decision with your friends and family.  You will also 
discuss it with your health care team.  If you have any questions, you can ask your study nurse 
for more explanation.   
 
You are being asked to take part in this research study because you have Prostate Cancer and 
have chosen Robotic Laparoscopic Prostatectomy surgery. 
 
The sponsor of this study is Fox Chase Cancer Center. 
 
Why is this research study being done? 
 
The purpose of this study is to find out the best pain management strategy for Robotic 
Laparoscopic Prostatectomy surgery.  We would like to find out what combination of 
medications works best after this surgery.  Ultimately, we would like to develop a “best practice” 
pain management strategy to address the needs of patients who undergo this surgery.  
 
You will receive the same care and medications chosen by your anesthesia provider whether or 
not you participate in this study.  These medications will be reviewed after your surgery is 
complete and compared to your pain score (your nurse will ask you to rate your pain as a part of 
your care). We do not know if you will benefit from this research study.  We can use what we 
learn from this research study to help other people with the same disease who undergo the 
same surgery. 
 
How many people will take part in this research study? 
 
About 23 people for each group (two groups) will be needed for this research.  A total of 46 
people will take part in this research study if able to fill groups evenly.   
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What will happen if you take part in this research study? 
 
Questionnaires 
Before you begin the study, we will ask you to fill out a Demographic Data Form which is a 
Questionnaire that will be filled out one time only and takes less than 5 minutes for completion.   
 
Prior to surgery, The Numerical Pain Intensity Scale (NRS) and Comfort Questionnaire will be 
completed. These questionnaires will tell us about your pain and your comfort.  It will take 
approximately 10-15 minutes to complete the Comfort Questionnaire. We will ask you to fill this 
out before your surgery one time and one time after your surgery for a total of two times (and 30 
minutes) during this research study. 
 
You do not have to answer any questions that make you uneasy.  Whether or not you answer 
any question will not affect your medical care.  We will keep the paper copies of the 
questionnaires in a locked file to protect your privacy.   
 
No tests or procedures will be required to participate in this study.  
 
Medication Review for group placement – You will not be required to do anything.  
Medications you had during surgery will be reviewed. 
 
Study Chart  
      
You will receive a questionnaire one time before your surgery and one time after your 
surgery describing your comfort for this research study. This [two questionnaires from 
before your surgery until you return to your room] is called a cycle in the research time 
frame.  The cycle will not be repeated.  The chart below shows what will happen to you 
during your participation in this research.  The left-hand column shows the day in the cycle 
and the right-hand column tells you what to do on that day. 
 
Cycle 1 – There is only one cycle 
Day  What you do 
Prior to Surgery 
Admission 
Fill out Demographic Data Sheet, Numeric Pain Intensity Scale for Pain & 
General Comfort Questionnaire (16-21 minutes total time). 
Day of Surgery  Report for Surgery, Fill out Numeric Pain Intensity Scale (1 minute total time).   
Recovery Room Numeric Pain Intensity Scale (1 minute total time) completed in PACU. 
Admission to Room 
Numeric Pain Intensity Scale & General Comfort Questionnaire (11-16 
minutes total time). 
Research after  
Admission to Room  
Researcher will Review Data for Medications Received & gather information 
Numeric Pain Intensity Scale from medical record. 
Conclusion No further information or Questionnaires Required. 
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How long will you be in the research study? 
 
The research study will be complete after you have been admitted to your room after your 
surgery and have completed the final Numeric Pain Intensity Scale & General Comfort 
Questionnaire.  Since there is no change in your care during this research, no follow up will be 
required.  You will continue follow up with your surgeon as directed.   
 
 
Can you stop being in the research study? 
 
Yes.  You can decide to stop at any time.  Tell the study coordinator if you are thinking about 
stopping or decide to stop.  He or she will tell you how to stop safely.  
 
It is important to tell the study coordinator if you are thinking about stopping so any risks can be 
evaluated as needed.  Another reason to tell your research coordinator that you are thinking 
about stopping is to discuss what followup care could be most helpful for you. 
 
Can you be removed from this research study? 
 
The study nurse may stop you from taking part in this research study at any time if he/she 
believes it is in your best interest; if you do not follow the research study rules; or if the research 
study is stopped. 
 
What side effects or risks can you expect from being in the research study? 
 
The study involves little risk for participants.  Your medical record review will reveal which group 
you will be placed into only after your care is complete. You will not receive any specific 
medications while taking part in this research.  You will not require any blood work or testing as 
a result of participation in this research.  You should talk to your study nurse about any issues 
that you may have while taking part in the research study.  
 
There may be a possible risk of negative feelings after you complete the General Comfort 
Questionnaire.  You should talk to your study nurse about any issues that you may have while 
taking part in the research study.   
 
Are there benefits to taking part in the study? 
Taking part in this study may or may not make your health better.  While your healthcare 
providers administer high quality care with monitored comfort and pain control, it would be more 
useful to compare the variety of treatment modalities.  This study may provide information to 
help us determine the best pain management strategy for the robotic laparoscopic procedure. 
An improved pain management strategy may improve pain control and comfort for a quick 
recovery, and it may also result in expedited discharge from the hospital.  Although there is no 
proof of this yet, we do know that the information from this study will help your healthcare team 
learn more about improving pain control and comfort for this specific type of surgery.  This 
information could help future cancer patients. 
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What other choices do you have if you do not take part in this research study? 
Your other choices may include: 
 
• Getting treatment or care for your cancer without being in a study  
• Taking part in another study  
• Getting no treatment  
 
Talk to your doctor about your choices before you decide if you will take part in this study. 
 
Will your medical information be kept private?  
We will do our best to make sure that the personal information in your medical record will be 
kept private.  However, we cannot guarantee total privacy.  Your personal information may be 
given out if required by law.  If information from this study is published or presented at scientific 
meetings, your name and other personal information will not be used.  
 
Organizations that may look at and/or copy your medical records for research, quality 
assurance, and data analysis include: 
• Fox Chase Cancer Center, Institutional Review Board 
• The National Cancer Institute (NCI) and other government agencies, like the Food and 
Drug Administration (FDA), involved in keeping research safe for people  
 
You will be given a separate form to review regarding the steps we will take to guard your 
privacy as part of your participation in the research study.  By signing that additional 
authorization, you will be providing your consent to use and disclose information described in 
that form connected with your participation in this research study. 
 
What are the costs? 
Taking part in this study may or may not cost your insurance company more than the cost of 
getting regular cancer treatment. 
 
Will you be compensated? 
You will not get paid for taking part in this research study.  If you are harmed because of the 
research study, we will provide the medical care to treat that harm.  However, you may have to 
pay for this treatment.  Fox Chase Cancer Center has not set aside funds to pay your salary if 
you cannot work or for any other damages if you are harmed because of the research study.   
 
What are your rights if you take part in this research study? 
Taking part in this research study is your choice.  You may choose either to take part or not to 
take part in the research study.  If you decide to take part in this study, you may leave the study 
at any time.  No matter what decision you make, there will be no penalty to you and you will not 
lose any of your regular benefits.  Leaving the study will not affect your medical care.  You can 
still get your medical care from our institution.  
In the case of injury resulting from this study, you do not lose any of your legal rights to seek 
payment by signing this form.  
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New findings 
We will tell you about new information or changes in the study that may affect your health or 
your willingness to continue in the study. 
 
Who can answer your questions about the research study? 
If you have questions about: Please Page: 
This study Kimberly A. Davis, DrNP(c), CRNA  
215-308-1262 
If you get sick or hurt in this study Kimberly A. Davis, DrNP(c), CRNA  
215-308-1262 
If you have a concern or complaint Director, Risk Management 
215-728-2591 
Your rights as a research participant while 
you are on this study or after the study ends 
Institutional Review Board 
215-214-3754 
Your bills or health insurance coverage Clinical Trial Financial Counselor 
215-214-3768 
 
Where can you get more information? 
You may call the National Cancer Institute's Cancer Information Service at:  
1-800-4-CANCER (1-800-422-6237)  
 
• You may also visit the NCI website at http://cancer.gov 
• For NCI's clinical trials information, go to: http://cancer.govclinicaltrials/  
• For NCI's general information about cancer, go to: http://cancer.gov/cancerinfo/  
By signing below, you tell us that you have gotten all of the information you need; that you have 
received clear answers to your questions, and that you agree to take part in the research study.  
You will receive a copy of this form.  You may also request a copy of the research plan.  
 
___________________________   ________________________           _____________ 
Signature of Participant  Print Name of Participant              Date 
 
____________________________   _______________________  ____________ 
Signature of Person   Print Name of Person   Date 
Obtaining Consent   Obtaining Consent 
 
By signing this form the Physician obtaining consent indicates that the research 
participant has been fully informed of all aspects of the research study. 
 
 
 
 
 
 
PAIN AND COMFORT AFTER PROSTATE SURGERY 124 
  
 
Appendix J 
Updated HIPPA with Temple Logo 
 
Authorization (Permission) to Use or Disclose (Release) 
Protected Health Information (PHI) for 
Research 
IRB# and Protocol ID: IRB #11-883  
Study Title:  Pain Management and Comfort in Robotic Laparoscopic Prostatectomy 
Patients 
Principal Investigator: Kimberly A. Davis, DrNP(c), CRNA 
Coordinating Group (or 
Center): 
Fox Chase Cancer Center 
Other Sponsor(s): 
 
 
3. What is the purpose of this form? 
This form is required by the Health Insurance Portability and Accountability Act of 1996.  Specifically 
the privacy regulation (HIPAA) permits the research investigators listed above to use and disclose health 
information about you for the research study identified above which has been approved by the Fox Chase 
Cancer Center Institutional Review Board. 
The Fox Chase Cancer Center is an organization that does research to learn about the causes of cancer, 
and how to prevent and treat cancer. Researchers would like to use your protected health information for 
research. The elements of protected health information as defined by HIPAA are: 
 
Data Elements for Protected Health Information (PHI) 
• Names 
• All geographic subdivisions smaller than a state (except for the first 3 digits of the zip code in 
some cases) 
• All elements of dates (except year) for dates directly related to an individual (e.g., birth date, 
admission date, discharge date, date of death) and all ages over age 89 and dates indicative of that 
age 
• Telephone numbers 
• Fax numbers 
• E-mail addresses 
• Social security numbers 
• Medical record numbers 
• Health plan beneficiary numbers 
• Account numbers 
• Certificate/license numbers 
• Vehicle identifiers and serial numbers, including license plate numbers 
• Device identifiers and serial numbers 
• Web Universal Resource Locators (URL) 
• Internet Protocol (IP) addresses 
• Biometric identifiers, including finger and voice prints 
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• Full face photos and any comparable images 
• Any other unique identifying number, characteristic, or code 
 
2. What protected health information do the researchers want to use? 
The researchers may want to copy and use the portions of your health information that they will need for 
their research. If you enter a research study, health information that maybe used and/or released include 
the following: 
• Personal medical history; 
• Family medical history; 
• Tissue/blood/cells/DNA; 
• Content of audio/video recording of sessions; 
• Current and past cancer screening and lifestyle practices, medications, therapies, 
diagnostic tests, surgeries, and/or biopsies; 
• Information from a genetic test you may have had in the past (for example, BRCA1 
and/or BRCA2 testing) 
• Any information collected in the Health History Questionnaire and/or other survey 
instruments completed during the course of the study. 
 
You may request a blank copy of the data forms from the study doctor or his/her research staff to learn 
what information will be shared. 
3. Why do the researchers want my protected health information? 
Fox Chase Cancer Center will collect your protected health information and share it with the Fox Chase 
Cancer Center Biostatistical Center if you enter a research study. The center will use your information in 
their cancer research study. 
4. Who will be able to use my protected health information? 
Fox Chase Cancer Center will use your health information for research. As part of this research, it may 
give your information to the following groups taking part in the research. Fox Chase Cancer Center may 
also permit these groups to come in to review your original records that are kept by Fox Chase Cancer 
Center so that they can monitor the research study. 
• The Fox Chase Cancer Center Biostatistical Center 
• Public health agencies and other government agencies (including non-U.S.) as authorized or 
required by law; 
• Other people or organizations assisting with research efforts of the Fox Chase Cancer Center 
5. How will information about me be kept private? 
Fox Chase Cancer Center will keep all health information private to the extent possible. Only researchers 
working with Fox Chase Cancer Center or the sponsor will have access to your information. Fox Chase 
Cancer Center or the sponsor will not release personal health information about you to others except as 
authorized or required by law. However, once your information is given to other organizations that are not 
required to follow federal privacy laws, we cannot assure that the information will remain protected. 
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6. What happens if I do not sign this permission form? 
If you do not sign this permission form, you will not be able to take part in the research study for which 
you are being considered. 
 
7. If I sign this form, will I automatically be entered into the research study? 
No, you cannot be entered into any research study without further discussion and separate consent. After 
discussion, you may decide to take part in the research study. At that time, you will be asked to sign a 
specific research consent form. 
Treatment by your physician will not be affected by whether you provide authorization for the requested 
use or disclosure except if your treatment is related to research. 
 
8. What happens if I want to withdraw my permission? 
You can change your mind at any time and withdraw your permission to allow your protected health 
information to be used in the research. If this happens, you must withdraw your permission in writing.  
Beginning on the date you withdraw your permission, no new protected health information will be used 
for research. However, researchers may continue to use the protected health information that was 
provided before you withdrew your permission.  If you sign this form and enter the research study, but 
later change your mind and withdraw your permission, you will be removed from the research study at 
that time. 
To withdraw your permission, please contact the person below. She will make sure your written request to 
withdraw your permission is processed correctly. 
Contact Name: Kimberly A. Davis, DrNP(c), CRNA 
Contact Address:  333 Cottman Avenue, Philadelphia, PA 
Contact Phone and FAX: Pager, 215 308 1262; Phone 215 728 3180; FAX 215 214 1734 
 
9. How long will this permission last? 
If you agree by signing this form that researchers can use your protected health information, this 
permission has no expiration date. However, as stated above, you can change your mind and withdraw 
your permission at any time. 
 
10. What are my rights regarding access to my personal health 
information? 
You have the right to refuse to sign this permission form. You have the right to review and/or copy 
records of your protected health information kept by Fox Chase Cancer Center.  
************************************************************************************
SSignatures 
I agree that my protected health information may be used for the research purposes described in this form. 
Participant Signature:         Date:     
or Legal Representative:        Date:      
Printed Name of Legal Representative (if any):          
************************************************************************************* 
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Prior to surgery, The Numerical Pain Intensity Scale (NRS) and Comfort Questionnaire will be 
completed. These questionnaires will tell us about your pain and your comfort.  It will take 
approximately 10-15 minutes to complete the Comfort Questionnaire. We will ask you to fill this 
out before your surgery one time and one time after your surgery for a total of two times (and 30 
minutes) during this research study. 
You do not have to answer any questions that make you uneasy.  Whether or not you answer any 
question will not affect your medical care.  We will keep the paper copies of the questionnaires 
in a locked file to protect your privacy.   
No tests or procedures will be required to participate in this study.  
 
Medication Review for group placement – You will not be required to do anything.  
Medications you had during surgery will be reviewed. 
 
Study Chart  
      
You will receive a questionnaire one time before your surgery and one time after your 
surgery describing your comfort for this research study. This [two questionnaires from 
before your surgery until you return to your room] is called a cycle in the research time 
frame.  The cycle will not be repeated.  The chart below shows what will happen to you 
during your participation in this research.  The left-hand column shows the day in the cycle 
and the right-hand column tells you what to do on that day. 
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Cycle 1 – There is only one cycle 
Day  What you do 
Prior to Surgery 
Admission 
• Fill out Demographic Data Sheet, Numeric Pain Intensity Scale for 
Pain & General Comfort Questionnaire (16-21 minutes total time). 
Day of Surgery  • Report for Surgery, Fill out Numeric Pain Intensity Scale (1 minute 
total time).   
Recovery Room • Numeric Pain Intensity Scale (1 minute total time) completed in 
PACU. 
Admission to 
Room 
• Numeric Pain Intensity Scale & General Comfort Questionnaire 
(11-16 minutes total time). 
Research after  
Admission to 
Room  
• Researcher will Review Data for Medications Received & gather 
information Numeric Pain Intensity Scale from medical record. 
Conclusion 
• No further information or Questionnaires Required. 
 
How long will you be in the research study? 
The research study will be complete after you have been admitted to your room after your 
surgery and have completed the final Numeric Pain Intensity Scale & General Comfort 
Questionnaire.  Since there is no change in your care during this research, no follow up will be 
required.  You will continue follow up with your surgeon as directed.   
 
Can you stop being in the research study? 
Yes.  You can decide to stop at any time.  Tell the study coordinator if you are thinking about 
stopping or decide to stop.  He or she will tell you how to stop safely.  
 
It is important to tell the study coordinator if you are thinking about stopping so any risks can be 
evaluated as needed.  Another reason to tell your research coordinator that you are thinking about 
stopping is to discuss what followup care could be most helpful for you. 
 
 
 
 
 
PAIN AND COMFORT AFTER PROSTATE SURGERY 130 
  
 
Appendix J (continued) 
 
Can you be removed from this research study? 
The study nurse may stop you from taking part in this research study at any time if he/she 
believes it is in your best interest; if you do not follow the research study rules; or if the research 
study is stopped. 
 
What side effects or risks can you expect from being in the research study? 
The study involves little risk for participants.  Your medical record review will reveal which 
group you will be placed into only after your care is complete. You will not receive any specific 
medications while taking part in this research.  You will not require any blood work or testing as 
a result of participation in this research.  You should talk to your study nurse about any issues 
that you may have while taking part in the research study.  
 
There may be a possible risk of negative feelings after you complete the General Comfort 
Questionnaire.  You should talk to your study nurse about any issues that you may have while 
taking part in the research study.   
 
Are there benefits to taking part in the study? 
Taking part in this study may or may not make your health better.  While your healthcare 
providers administer high quality care with monitored comfort and pain control, it would be 
more useful to compare the variety of treatment modalities.  This study may provide information 
to help us determine the best pain management strategy for the robotic laparoscopic procedure. 
An improved pain management strategy may improve pain control and comfort for a quick 
recovery, and it may also result in expedited discharge from the hospital.  Although there is no 
proof of this yet, we do know that the information from this study will help your healthcare team 
learn more about improving pain control and comfort for this specific type of surgery.  This 
information could help future cancer patients. 
 
What other choices do you have if you do not take part in this research study? 
 
Your other choices may include: 
• Getting treatment or care for your cancer without being in a study  
• Taking part in another study  
• Getting no treatment  
Talk to your doctor about your choices before you decide if you will take part in this study. 
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Will your medical information be kept private?  
 
We will do our best to make sure that the personal information in your medical record will be 
kept private.  However, we cannot guarantee total privacy.  Your personal information may be 
given out if required by law.  If information from this study is published or presented at scientific 
meetings, your name and other personal information will not be used.  
 
Organizations that may look at and/or copy your medical records for research, quality assurance, 
and data analysis include: 
• Fox Chase Cancer Center, Institutional Review Board 
• The National Cancer Institute (NCI) and other government agencies, like the Food and 
Drug Administration (FDA), involved in keeping research safe for people  
 
You will be given a separate form to review regarding the steps we will take to guard your 
privacy as part of your participation in the research study.  By signing that additional 
authorization, you will be providing your consent to use and disclose information described in 
that form connected with your participation in this research study. 
What are the costs? 
Taking part in this study may or may not cost your insurance company more than the cost of 
getting regular cancer treatment. 
 
Will you be compensated? 
You will not get paid for taking part in this research study.  If you are harmed because of the 
research study, we will provide the medical care to treat that harm.  However, you may have to 
pay for this treatment.  Fox Chase Cancer Center has not set aside funds to pay your salary if you 
cannot work or for any other damages if you are harmed because of the research study.   
 
What are your rights if you take part in this research study? 
Taking part in this research study is your choice.  You may choose either to take part or not to 
take part in the research study.  If you decide to take part in this study, you may leave the study 
at any time.  No matter what decision you make, there will be no penalty to you and you will not 
lose any of your regular benefits.  Leaving the study will not affect your medical care.  You can 
still get your medical care from our institution.  
 
In the case of injury resulting from this study, you do not lose any of your legal rights to seek 
payment by signing this form.  
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New findings 
 
We will tell you about new information or changes in the study that may affect your health or 
your willingness to continue in the study. 
 
Who can answer your questions about the research study? 
If you have questions about: Please Page: 
This study Kimberly A. Davis, DrNP(c), CRNA  
215-308-1262 
If you get sick or hurt in this study Kimberly A. Davis, DrNP(c), CRNA  
215-308-1262 
If you have a concern or complaint Director, Risk Management 
215-728-2591 
Your rights as a research participant while 
you are on this study or after the study ends 
Institutional Review Board 
215-214-3754 
Your bills or health insurance coverage Clinical Trial Financial Counselor 
215-214-1727 
 
Where can you get more information? 
You may call the National Cancer Institute's Cancer Information Service at:  
 
1-800-4-CANCER (1-800-422-6237)  
• You may also visit the NCI website at http://cancer.gov 
• For NCI's clinical trials information, go to: http://cancer.govclinicaltrials/  
• For NCI's general information about cancer, go to: http://cancer.gov/cancerinfo/  
 
By signing below, you tell us that you have gotten all of the information you need; that you have 
received clear answers to your questions, and that you agree to take part in the research study.  
You will receive a copy of this form.  You may also request a copy of the research plan.  
___________________________   ________________________           _____________ 
Signature of Participant  Print Name of Participant              Date 
____________________________   _______________________  ____________ 
Signature of Person   Print Name of Person   Date 
Obtaining Consent   Obtaining Consent 
By signing this form the Physician obtaining consent indicates that the research participant 
has been fully informed of all aspects of the research study. 
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1.0 SCHEMA 
 
Inclusion Criteria: 
1. Adult Male subjects age 18 and older 
2. Those who are scheduled for RALP* 
3. Willing to participate in study 
4. Anesthesia standard of care includes opioids with or without α 2 agonist 
Exclusion Criteria: 
1. Dependent upon others to make health care decisions 
2. If anesthetic/surgical event in which participant is unable to complete pain and 
comfort scale or conversion of RALP procedure to open radical prostatectomy 
3. Applicable group at required statistical participant level 
4. No Opioids used 
*RALP = Robotic Assisted Laparoscopic Prostatectomy 
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2.0 OBJECTIVES 
  
The purpose of this study is to determine the best pain management strategy for this 
robotic laparoscopic procedure, both improving pain control and comfort for a facilitated 
recovery and expedited discharge from the hospital.  A procedure specific approach to peri-
operative pain management is appropriate to optimize multimodal pain management strategies 
(White & Kehlet, 2010).   
  
The long-term goal of this project therefore is to develop a best practice pain 
management strategy to address the needs of Robotic Assisted Laparoscopic Prostatectomy 
(RALP) patients’ through improvement of comfort and pain control.  The objective of this study 
is to identify the relationship of pain management to comfort in this robotic surgical population 
through comparison of two standards of anesthesia care protocol in the peri-operative setting.   
 
The specific aims of this project are: 
 
1.  Compare the effect of 2 pharmaceutical regimens on pain and comfort in the 
laparoscopic robotic prostatectomy patient.  The null hypothesis:  There will be no 
difference between two standard anesthesia protocols with regard to pain and comfort prior 
to surgery, admission to PACU after surgery, discharge from PACU, and admission to the 
Surgical Unit. 
2. Explore the relationship between pain and comfort in post-operative RALP patients.  
The null hypothesis:  Decreased pain will not be associated with increased comfort. 
 
3.0 BACKGROUND 
 
Pain assessment and management has become a priority to many stakeholders including 
medical caregivers, patients, health care organizations and credentialing agencies. “Pain is 
whatever the experiencing person says it is, existing whenever the experiencing person says it 
does (McCaffery & Beebe, 1989, p. 7).”  The Joint Commission (TJC) in 2000 began including 
pain control as a part of the national standards and accreditation process (TJC, 2009).  California 
has passed regulations regarding pain as the 5th vial sign (State of California Department of 
Consumer Affairs, 2000) and the Veterans Administration published a 57 page toolkit 
implementing a Veteran Health Administration (VHA) National Pain Management Strategy to 
promote pain as the 5th vital sign and offer guidelines for comprehensive pain assessment 
(Department of Veteran Affairs, 2000).  Further, pain plays a significant role in consumer 
satisfaction.  Consumer satisfaction is a growing interest which is important to all stakeholders, 
including health care providers.  Consumers satisfaction with care related to pain and comfort 
have been shown to be highly correlated to scores on the Hospital Consumer Assessment of 
Healthcare Providers and Systems (HCAHPS) survey with a Cronbach’s alpha, 0.94, and 
correlation coefficient 0.84 for communication and adequate pain control (Jha, Orav, Zheng & 
Epstein, 2008).   
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Wilson and Kolcaba (2004), describe a comfort theory relating to nursing which depicts the 
importance for enhanced comfort in patients.  Comfort has many meanings and connotations; it 
is much more than ease or relief of discomfort.  Holistic comfort may include physical, 
psychospiritual, sociocultural, and environmental needs (Wilson & Kolcaba).  Comfort is defined 
as “the immediate state of being strengthened through having the human needs for relief, ease, 
and transcendence (types of comfort) addressed physically, psychospiritually, socioculturally, 
and environmentally (contexts in which comfort is experienced) (Kolcaba, 2003, p. 251).”  
 
Although pain is reduced in minimally invasive surgery, there is a gap in the literature 
describing pain and comfort management with therapeutic regimens.  Therapeutic regimens 
are recommended plans of care.  This may be a protocol for pain management, such as specific 
groups of medications found to be most effective for care during surgery.  A wide array of 
pharmacologic agents may be used independently or combined for pain control and comfort.  
Variation of pharmacologic selections may be practitioner dependent.  Optimizing pain control 
and comfort levels are key issues important in facilitating a rapid recovery and patient discharge.         
 
Seventy five million Americans suffer from serious or severe pain and 50 million of those 
people endure chronic daily pain serious enough to affect their quality of life (Yass, 2009). The 
American Pain Society has created a mission to serve people in pain through advancing research, 
education, treatment, and professional practice. The under treatment of pain in today's society is 
not justified.  With a growing trend toward laparoscopic procedures, specifically robotic 
laparoscopic; it is important to determine the effectiveness of pain and comfort in the peri-
operative period.  Pain management and comfort are important goals to achieve in order to 
facilitate and improve patient care and outcomes.   
 
Pain control modalities and treatments in this research proposal focus specifically on 
pharmacologic modalities. 
Opioid Sparing 
Opioid sparing is a modality used to reduce side effects of medications.  A non-opioid 
medication used in combination with opioids to reduce opioid requirements is termed 
opioid-sparing. Significant side effects of opioids can interfere with recovery and reduce a 
patient’s comfort level (Kehlet, 2005).  Using opioid dose sparing strategies assists in 
alleviating harsh side effects (Wheeler, Oderda, Ashburn & Lipman, 2002).  Multimodal 
balanced analgesia applies the opioid sparing technique leading to a reduction in adverse 
effects of opioids (Kehlet).  The Joint Commission has set a standard for pain management 
to reduce patients’ pain (Kehlet).  If this goal is achieved though opioids alone, there is an 
increased risk of adverse effects (Kehlet).  Although the National Institute of Health (NIH) 
practice guidelines suggest opioids be the primary mode of analgesia, concerns related to 
adverse effects are significant (Wheeler, Oderda, Ashburn & Lipman).  Many studies have 
shown the benefits of multimodal analgesia with a variety of differing cases; however; there 
is limited information on this approach after robotic surgery.   
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Multimodal Analgesia 
Multimodal analgesia a modality used to reduce side effects of medications.  Multimodal 
balanced analgesia can help to reduce adverse outcomes generally associated with opioids 
alone.  Rationale for multimodal analgesia is to reduce the dose of each analgesic which 
improves anti-nocioception due to synergistic or additive effects; this may reduce the 
severity of side effects (Kehlet & Dahl, 1993).  The goal of multimodal analgesia is opioid 
sparing which reduces postoperative morbidity and medication related complications 
(White, Kehlet & Liu, 2009; Classen, 1997).  Combining analgesics from differing drug 
classes improves safety and efficacy through the variety of each drugs mechanism of action 
(White & Kehlet, 2010).     
 
Pharmacologic Agents 
A variety of medications may provide postoperative analgesia.  Analgesia is defined as the 
insensibility of pain without loss of consciousness (analgesia, 2010).  Many different 
combinations of pharmacologic agents may be used to produce analgesia, including local 
anesthetics, opioids, and alpha-2 agonists.  Dexmedetomidine is an alpha-2 adrenergic 
agonist which provides sedation while decreasing anesthetic use without respiratory 
depression (Davis, Waters, Vinson, Eddy & Vick, 2000).  Although opioids reduce pain, 
side effects associated with these agents may contribute to discomfort (Wu, et al., 2005).  
Further, use of local anesthetics at port and incision sites can improve patients’ pain and 
comfort, and further reduce opioid requirements.   
 
The two standards of care anesthetic regimens proposed for this research will provide further 
information on both the multimodal balanced analgesia and opioids alone approach to pain 
management.  Further identification of single agent pain control compared to two agents will 
guide our practice to the best pain management strategy for this robotic laparoscopic procedure.  
Therefore the two protocol groups will be those participants who received opioids alone and 
those who received opioids with an α 2 agonist.   
 
As the use of robotics continues to grow and diversify, new criteria come to light with a 
focus on pain control, reducing invasiveness and promoting early discharge.  A variety of 
pharmacologic agents have been used to treat pain and improve comfort in this population.  Each 
patient may have more than one analgesic agent which may be termed “multimodal therapy”.  
Multimodal therapy combines analgesics with differing mechanisms of action to create a 
synergistic effect, thereby reducing total doses of each drug (Kamming, Chung, Williams, 
McGrath & Curti, 2004).  This method allows a reduction of opioid requirements and the side 
effects frequently associated with them (Kamming, et. al.). Analgesia protocols may assist in 
reducing variance of practice and improve pain management (Kamming, et. al.).  The purpose of 
this study is to determine the best pain management strategy for this robotic laparoscopic 
procedure, both improving pain control and comfort for a facilitated recovery and expedited 
discharge from the hospital.  A procedure specific approach to peri-operative pain management 
is appropriate to optimize multimodal pain management strategies (White & Kehlet, 2010).    
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This study will provide a scientific base for development of improved pharmacologic pain 
and comfort interventions.  Pain and comfort in this relatively new procedure has not been 
adequately addressed.  This study will provide important information about the efficacy of pain 
management in the immediate postoperative period by comparing two anesthetic regimens.  The 
results could be used to guide future anesthetic practice.  
 
Kimberly A. Davis, DrNP(c), CRNA is a candidate for Drexel University Doctoral Nursing 
Research Program and this research is required for program completion. Doctoral Candidate 
Davis has been a practicing RN for 22 years and CRNA for 11 of those years.  Her interest in 
pain management led her to a career in Anesthesia and her Doctoral work is focused on this area 
combining minimally invasive procedures and pain management strategies.  A consultation with 
Dr. Andrea Barsevick provided further insight into research development at Fox Chase Cancer 
Center.  The entire Urology Team at Fox Chase Cancer Center is Co-Investigators and Dr. Fang 
Zhu will provide statistical analysis and support throughout the proposal and research. 
 
4.0 STUDY DESIGN 
 
This proposal is an Observational Descriptive Study with No Intervention.  The research 
study is a prospective quantitative study with a convenience sample.  This will be a cross 
sectional study controlling for procedure type.  Groups will be defined after treatment is 
complete, ensuring no manipulation of plan of care or treatment strategy.  A retrospective chart 
review will be used to determine group placement of participants: Group A or Group B.    
 
5.0 PATIENT SELECTION 
 
A convenience sample from a Philadelphia institution will provide recruitment of subject 
pool.  Fox Chase Cancer Center is located in Northeast Philadelphia, PA.   
 
Inclusion Criteria: 
1. Adult Male subjects age 18 and older 
2. Those who are scheduled for RALP 
3. Willing to participate in study 
4. Anesthesia standard of care includes opioids with or without α 2 agonist 
Exclusion Criteria: 
1. Dependent upon others to make health care decisions 
2. If anesthetic/surgical event in which participant is unable to complete pain and 
comfort scale or conversion of RALP procedure to open radical prostatectomy 
3. Applicable group at required statistical participant level 
4. No Opioids used 
*RALP = Robotic Assisted Laparoscopic Prostatectomy 
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6.0 SURVEY PROCEDURES 
The Primary Investigator (PI) Kimberly Davis, will be project staff.  Fox Chase Cancer Center 
RRC & IRB review of Proposed Research. Drexel University RRC & IRB review of Proposed 
Research.  Once approved by both Fox Chase Cancer Center & Drexel University, begin 
research study.  Individuals scheduled for RALP at Fox Chase Cancer Center will be potential 
participants for this study.  All adult males who meet the inclusion criteria will be offered an 
opportunity to participate in this research study.  These individuals will be approached to offer 
participation in this study. Informed consent and HIPAA authorization forms will be obtained.  
Candidates will be recruited either in the physicians offices or pre-operatively.  If criteria is met 
for recruitment, and potential candidate is interested in participating after a full explanation of 
the research, informed consent will be obtained.  Within two weeks of preoperative admission, 
the participant will be given the Demographic Data Sheet (DDS), The Numerical Rating Scale 
(NRS) and General Comfort Questionnaire (GCQ) to complete. Within ten minutes of PACU 
admission and at PACU discharge, the NRS will be assessed as standard of care.  Final 
assessment will be completed within sixty minutes of arrival to medical/surgical room, the NRS 
and GCQ will be repeated.  Medical Record Evaluation will provide medications received 
intraoperatively and in PACU.  This will place participant in Group A or B.   
 
7.0 MEASUREMENT OF EFFECT 
 
Demographic Data Form:   
Fourteen items are on the Demographic Data Sheet (DDS).  A one time completion of DDS will 
be evaluated with an Estimated Time for DDS completion < 5 minutes.  This questionnaire will 
collect data documenting age, marital status, ethnicity, education level, socioeconomic status, 
race, history of chronic pain, daily pain medication list, cigarette smoking, exercise, hair color & 
how participant deals with pain and what alternate emotional/spiritual may have been used in the 
past to improve comfort and reduce pain.   
 
Numerical Rating Scale (0-10 Pain Scale):   
Numeric Pain Rating Scale (NRS) will ask the participant to rate intensity of their pain on a 0-10 
scale.  This self report of pain describes pain in a numeric form on a graduated scale with 0 = No 
Pain and 10 = Severe pain or worst pain imaginable (NIH, 2003).  Use of the Numerical Rating 
Scale (NRS) has been established as reliable and valid (Williamson & Hoggart, 2005).  The NRS 
is frequently used in the postoperative period to evaluate pain.  Numerical Rating Scale will be 
evaluated four times (pre-op, post-op upon PACU arrival and discharge, and upon arrival to 
medical/surgical unit).  These measures are done by registered nurses.  Education will be 
provided to all nurses regarding the Numerical Rating Scale.  The following script will be used 
to rate pain:  “On a scale of 0-10, 0 = No pain, 10 = Worst pain, please rate your pain.  There is 
no right or wrong answer”.  Estimated time to completion NRS < 1 minute.    
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General Comfort Questionnaire (GCQ):   
A 28 item 6 response multiple choice likert scale instrument rating from strongly agree to 
strongly disagree (Kolcaba, 1992).  Several modifications of this instrument are available with 
high reliability.  Initial results for the original form of the Principal Components Analysis (PCA) 
showed all items measuring a single construct with a Cronbach’s alpha = 0.88 (Kolcaba, 1992).  
Thirteen factors were extracted with eigenvalue > 1 (Kolcaba, 1992).  Revised reliabilities 
increased Cronbach’s alpha = 0.90 (Kolcaba, 1992).  This instrument showed statistically 
significant sensitivity in the expected directions between several groups (Kolcaba, 1992).  This 
questionnaire will be completed one time pre-op and one time post-operatively (medical-surgical 
unit).  This questionnaire takes about 10-15 minutes to complete.   
 
Chart Review for Grouping & Data Analysis:  Medications used in the OR and PACU will be 
recorded as well as participant age, height, weight, length of PACU stay and NRS score.  
 
8.0 DATA MANAGEMENT 
All hard copy information will be kept in a locked & secure drawer in the Anesthesia CRNA 
Office with limited access to Primary PI.  All electronic data will be stored on a secured 
username & encrypted password computer and flash (USB drive) which will be locked in the 
secured information drawer when not in use by the PI.  Microsoft Office Exel & Microsoft 
Office Word with be created for information gathering and database use.   
 
9.0 STATISTICAL CONSIDERATIONS 
9.0.1 Specific Aim 1 is to explore the effect of 2 groups of pharmaceutical regimens on pain and 
comfort in the laparoscopic robotic prostatectomy patient.  The null hypothesis:  Pain and 
comfort will not vary among the two pharmaceutical regimens.  
Group A:  Opioids  
Group B:  Opioids + α 2 agonist 
 
Data will be summarized as means and standard deviation for continuous variables and 
frequencies for categorical and discrete variables.  Baseline demographics and preoperative 
variables will be compared by treatment.  Because a randomization for this study is not feasible, 
this will allow us to check for unbalance between treatment arms.  If any unbalance is found, we 
will use model adjustment to account this.  For the primary outcome, pain and comfort will be 
measured before surgery and at 3 post surgery time points.  To test the treatment effect on pain 
scale score and comfort score, we will use a hierarchical linear modeling (HLM) where level 1 is 
the individual observation repeated over time and level 2 is the individual within which the 
observations are nested.  Compare to a more traditional repeated measure ANOVA, this 
maximum likelihood based method will allow us to use all available data the individual provides, 
even if some of it is missing.  We will also adjust for any unbalanced factors that were identified 
in the preliminary analysis by including them as covariates.  The model will also include time of 
the assessment, treatment arm and the interaction between treatment and time.  Because this is a 
pilot study, we will not adjust for multiple comparisons. 
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9.0.2  
Specific Aim 2:  The specific aim 2 is to explore the relationship between pain and comfort in 
post-operative RALP patient.  The null hypothesis:  Decreased pain will not be associated with 
increased comfort. 
 
We will use simple bivariate correlations.  The correlations will be computed at each time point 
and tested against the correlation of zero.   
 
9.0.3  
Determination of Sample Size 
Poser was first assessed for the repeated-measures ANOVAs.  Simulations have been shown that 
HLM and repeated-measures ANOVAs have similar power pattern when same data were used 
(FANG, 2006).  We expect our method will be three groups in the study:  because all partially 
observed data re included.  There will be two groups in the study:   
Group A:  Opioids 
Group B:  Opioids + α 2 agonist 
There will be two dependent variables for the ANOVAs (pain scale score, comfort score); each 
will be evaluated on the interval scale of measurement.  Therefore, the study will employ two, 
repeated-measures ANOVAs, one ANOVA for each of the two dependent variables.   
 
A priori power was estimated for the univariate repeated-measures ANOVAs.  The analyses 
assumed that the sphericity requirement was met (Stevens, 2002; Tabachnick & Fidell, 2007).  
The proposed analysis will use a two-tailed alpha level set to .05.  Overall power was set to .80, 
meaning the study will have an 80% probability of finding a significant difference if such a 
difference exists in the population.  Equal sample sizes were assumed.  The power analysis 
concentrated on the multivariate group-by-time interaction because4 it usually is the least 
powerful element in a repeated measures ANOVA (Field, 2009; Wickens & Keppel, 2004).  A 
medium effect size was anticipated (Cohen’s {1988} f = .25).  Results showed an overall sample 
size of 38 would be required (19 subjects per group), assuming the correlation between the 
observation from the same subject is at least 0.2. This sample size was selected as the smallest 
sample that would be important to detect.  Recruitment will continue until both groups A & B of 
23 per group are filled.  This will assume 15% attrition.       
 
The study will also calculate the bivariate association between pain and comfort scores for 
robotic laparoscopic prostatectomy patients.  Therefore, a second power analysis was completed.  
Power for the bivariate analysis was set to .80. A large effect size was postulated (i.e., Cohen’s 
{1988} r = .50.  Results showed that an N of 26 would be required.  
 
Given the discrepancy between the two power analyses, the more conservative sample size will 
be employed.  In other words, the sample will employ 46 participants.  This sample size will be 
sufficient for both the repeated-measures ANOVAs and the bivariate-correlation analyses.    
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10.0 HUMAN SUBJECTS 
 
Protection of Human Subjects 
 
The study introduces little risk for subjects. Vulnerable populations such as age have been 
restricted in this study setting parameters at > 18 years of age since < 18 years of age are 
considered a vulnerable population.  Informed consent will clearly inform individuals of the 
studies nature.  Intent to ensure confidentiality will be clearly indicated within the consent.  
Potential candidates will review the consent with a written description of the purpose, protocol, 
risk/benefit of research participation.  Participants will be allotted time for discussion, and 
provided the opportunity to ask questions prior to signing the consent.  Upon candidates ability 
to state purpose and expectations of study, written consent will be obtained.  The Principal 
Investigator (PI) or Sub-Investigator will obtain written informed consent from candidates who 
meet inclusion criteria.  Informed consent will include discussion of a voluntary basis inclusion 
with ability to withdrawal at any time.  Informed consent will be given to the participant, and one 
kept with the Principal Investigator.     
 
Participant pool will be recruited either in the physicians offices or pre-operatively.  In a 
confidential setting, individuals will be asked if they are interested in participating in the study, if 
so, consent will be obtained.  At this time, an identification number will be assigned to ensure 
confidentiality requesting all participants to place this number on any paperwork.  This 
information will be stored in a locked file cabinet by the PIs.  Only the PIs will have access to 
this information.  Data will be transcribed to a secure computer and accessed only by the PIs, 
further password protected.  Analysis of data will occur in month 4 with manuscript preparation 
in month 5.  After project completion, all information will be kept in a locked secure location by 
the Primary PI for seven years, after which time the data will be shredded and electronic data 
will be deleted.             
 
Inclusion of Women as Subjects 
The RALP procedure is performed only on men, which excludes women from this population of 
interest.   
 
Inclusion of Children as Subjects 
No children will be recruited for this study, as children are not included in the population of 
interest.   
 
Inclusion of Minority as Subjects 
Statistically, prostate cancer has a higher prevalence in African American men than Caucasian 
men.  There are no exclusions for minorities in subject recruitment.  All ethnicities that meet the 
study inclusion criteria are eligible. 
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Data and Safety Monitoring Plan  
This study will not implement a Phase I, II, or III clinical trial, so a formal data and safety 
monitoring plan will not be proposed.       
 
Compensation to Subjects 
There will be no compensation provided to the study participants. 
 
Vertebrate Animals   
This study is using human subjects only. 
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